Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_adsipsc_promoter_n_PM_14_119_21			3	0.6	1.71E-05	ACYP1, ANXA5	acylphosphatase activity [MF], endothelial microparticle [CC]
CG_adsipsc_promoter_n_PM_12_324_9			1	0.2	4.13E-04	CDK5, NGB, MAD2L2	acetylcholine receptor activator activity [MF], zeta DNA polymerase complex [CC], perikaryon [CC]
CG_adsipsc_promoter_n_PM_12_459_10			2	0.4	1.61E-04	PLA2G4D, PLA2G4C	phosphatidylinositol acyl-chain remodeling [BP], phospholipid catabolic process [BP], phosphatidylethanolamine acyl-chain remodeling [BP], phospholipase A2 activity [MF], phosphatidylcholine acyl-chain remodeling [BP]
CG_adsipsc_promoter_n_PM_16_64_12			2	0.4	1.72E-04	ABR, FECH, CAMK2N2	detection of UV [BP], ferrochelatase activity [MF], calcium-dependent protein kinase inhibitor activity [MF], iron-responsive element binding [MF], regulation of eIF2 alpha phosphorylation by heme [BP], negative regulation of neutrophil degranulation [BP]
CG_adsipsc_promoter_n_PM_12_11_7			1	0.2	7.26E-05	CHKA, NACC2	choline kinase activity [MF], negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_PM_16_26_15			2	0.4	3.13E-05	SELE, CLN3, ADAM10	response to tumor necrosis factor [BP], neuron projection [CC]
CG_adsipsc_promoter_n_PM_14_116_10			1	0.2	1.94E-05	TFRC, RS1, PIF1	adaptation of rhodopsin mediated signaling [BP], transferrin receptor activity [MF], single-stranded DNA-dependent ATP-dependent DNA helicase activity [MF], ATP-dependent 5'-3' DNA/RNA helicase activity [MF]
CG_adsipsc_promoter_n_PM_12_69_10			1	0.2	2.70E-05	SCARA5	ferritin receptor activity [MF]
CG_adsipsc_promoter_n_PM_16_56_16			1	0.2	5.50E-05	NLRP12, HAND1	embryonic heart tube formation [BP], negative regulation of Toll signaling pathway [BP], regulation of interleukin-18 biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_12_197_7			4	0.8	1.21E-04	ATPAF1, SPHKAP, STARD7, TP53AIP1, SERAC1	mitochondrion [CC]
CG_adsipsc_promoter_n_PM_12_418_12			2	0.4	3.46E-05	MPO	hypochlorous acid biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_12_348_18			2	0.4	8.95E-05	XPO5, ENTPD4	gene silencing by RNA [BP], UDP catabolic process [BP]
CG_adsipsc_promoter_n_PM_14_118_10			2	0.4	2.27E-05	BCL2, MCL1	BH3 domain binding [MF], response to acid [BP], negative regulation of apoptotic signaling pathway [BP], negative regulation of anoikis [BP]
CG_adsipsc_promoter_n_PM_12_355_11			2	0.4	1.74E-04	APRT	AMP salvage [BP], adenine binding [MF], adenine salvage [BP], adenine phosphoribosyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_191_9			1	0.2	1.36E-04	GPC4, SIX1, CDK11B, WNT7B, LGR4	metanephric epithelium development [BP], cell proliferation [BP], positive regulation of branching involved in ureteric bud morphogenesis [BP]
CG_adsipsc_promoter_n_PM_12_112_14			4	0.8	1.02E-04	FANCB, C1orf86	Fanconi anaemia nuclear complex [CC]
CG_adsipsc_promoter_n_PM_16_7_46			5	1.0	5.03E-05	DAPK2	autophagic vacuole lumen [CC]
CG_adsipsc_promoter_n_PM_12_383_9			2	0.4	2.38E-05	GAS6, NUDT18	GDP catabolic process [BP], 8-oxo-dGDP phosphatase activity [MF], negative regulation of dendritic cell apoptotic process [BP], negative regulation of fibroblast apoptotic process [BP], viral entry into host cell via membrane fusion with the plasma membrane [BP], virion attachment, binding of host cell surface receptor [BP], positive regulation of glomerular filtration [BP], negative regulation of interleukin-1 secretion [BP], cellular response to vitamin K [BP], 8-oxo-GDP phosphatase activity [MF], negative regulation of protein import into nucleus, translocation [BP], dADP catabolic process [BP], negative regulation of interleukin-6 secretion [BP], dGDP catabolic process [BP], negative regulation of renal albumin absorption [BP], negative regulation of oligodendrocyte apoptotic process [BP], hematopoietic stem cell migration to bone marrow [BP], 8-hydroxy-dADP phosphatase activity [MF]
CG_adsipsc_promoter_n_PM_12_473_8			4	0.6	4.53E-05	P2RY4	UTP-activated nucleotide receptor activity [MF]
CG_adsipsc_promoter_n_PM_12_181_18			2	0.4	1.23E-04	NAPRT1, GMDS, APRT	nicotinate nucleotide salvage [BP], adenine binding [MF], adenine phosphoribosyltransferase activity [MF], NADP+ binding [MF], GDP-mannose 4,6-dehydratase activity [MF]
CG_adsipsc_promoter_n_PM_18_27_33			4	0.8	5.32E-05	PLA2G4F, ENPP2	phospholipid catabolic process [BP], lysophospholipase activity [MF]
CG_adsipsc_promoter_n_PM_12_199_13			3	0.6	1.23E-04	KCNN4, LHCGR, GABBR1, TGFB1	defense response to fungus, incompatible interaction [BP], luteinizing hormone receptor activity [MF], choriogonadotropin hormone receptor activity [MF], G-protein coupled receptor dimeric complex [CC], negative regulation of hyaluronan biosynthetic process [BP], stabilization of membrane potential [BP], positive regulation of NAD+ ADP-ribosyltransferase activity [BP], choriogonadotropin hormone binding [MF]
CG_adsipsc_promoter_n_PM_12_462_18			1	0.2	8.18E-05	TOP2A, TERT	positive regulation of retroviral genome replication [BP], mitotic cell cycle G2/M transition decatenation checkpoint [BP], DNA topoisomerase complex (ATP-hydrolyzing) [CC], telomeric template RNA reverse transcriptase activity [MF], telomeric RNA binding [MF], viral integration complex [CC]
CG_adsipsc_promoter_n_PM_12_195_9			1	0.2	3.45E-04	NR0B1, DERL2, NPLOC4, AKR7A2, COQ3, CRAT	3-demethylubiquinone-9 3-O-methyltransferase activity [MF], DNA hairpin binding [MF], 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [MF], ER-associated protein catabolic process [BP], phenanthrene-9,10-epoxide hydrolase activity [MF], carnitine O-acetyltransferase activity [MF], hexaprenyldihydroxybenzoate methyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_202_16			1	0.2	5.37E-05	DYNLT1, CDK5RAP2	establishment of mitotic spindle orientation [BP]
CG_adsipsc_promoter_n_PM_12_127_12			3	0.6	5.00E-05	BCDIN3D, NACA, CENPJ, IL10	negative regulation of chronic inflammatory response to antigenic stimulus [BP], negative regulation of myeloid dendritic cell activation [BP], gamma-tubulin small complex [CC], interleukin-10 receptor binding [MF], negative regulation of interferon-alpha biosynthetic process [BP], nascent polypeptide-associated complex [CC], negative regulation of transcription from RNA polymerase II promoter involved in heart development [BP], negative regulation of pre-miRNA processing [BP], RNA methyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_430_9			2	0.4	2.81E-05	DDC	aromatic-L-amino-acid decarboxylase activity [MF], synaptic vesicle amine transport [BP], phytoalexin metabolic process [BP]
CG_adsipsc_promoter_n_PM_12_391_12			2	0.4	1.04E-04	PION	regulation of proteolysis [BP]
CG_adsipsc_promoter_n_PM_18_38_142			5	0.8	7.46E-05	SLC7A5, NCALD, SLC38A7	L-amino acid transmembrane transporter activity [MF], clathrin coat of trans-Golgi network vesicle [CC], amino acid transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_PM_14_73_15			2	0.4	4.34E-05	SEC23A, RAD54B, ARRDC3, AP1M2	negative regulation of heat generation [BP], DNA translocase activity [MF], negative regulation of locomotion involved in locomotory behavior [BP], positive regulation of adrenergic receptor signaling pathway [BP], vesicle targeting [BP], cellular membrane organization [BP], antigen processing and presentation of exogenous peptide antigen via MHC class II [BP], beta-3 adrenergic receptor binding [MF]
CG_adsipsc_promoter_n_PM_12_212_16			2	0.4	7.06E-05	STAR, OSBPL10	cellular response to luteinizing hormone stimulus [BP], cholesterol binding [MF]
CG_adsipsc_promoter_n_PM_12_225_10			1	0.2	1.55E-04	SCARA5, CYP7B1	ferritin receptor activity [MF], 25-hydroxycholesterol 7alpha-hydroxylase activity [MF]
CG_adsipsc_promoter_n_PM_12_289_18			2	0.4	1.29E-05	MYBPC3	regulation of muscle filament sliding [BP], C zone [CC], myosin heavy chain binding [MF], striated muscle myosin thick filament [CC], ATPase activator activity [MF]
CG_adsipsc_promoter_n_PM_16_3_9			2	0.4	8.25E-05	CANT1, PSMB1, FUT5	proteasome complex [CC], Golgi cisterna membrane [CC]
CG_adsipsc_promoter_n_PM_12_75_4			3	0.4	1.29E-05	SALL1, EPHA2, CSF1R	notochord cell development [BP], histone deacetylation [BP], transmembrane receptor protein tyrosine kinase activity [MF], bone remodeling [BP], inductive cell-cell signaling [BP], mammary gland duct morphogenesis [BP], osteoclast differentiation [BP]
CG_adsipsc_promoter_n_PM_12_227_6			2	0.4	5.11E-05	ADPGK, IRS2, WNT7B, LTA4H	establishment or maintenance of polarity of embryonic epithelium [BP], outer medullary collecting duct development [BP], leukotriene-A4 hydrolase activity [MF], ADP-specific glucokinase activity [MF], glucose metabolic process [BP]
CG_adsipsc_promoter_n_PM_12_143_14			2	0.4	4.40E-05	NME6, MAGT1, MMGT1	magnesium ion transport [BP], magnesium ion transmembrane transporter activity [MF], negative regulation of mitosis [BP]
CG_adsipsc_promoter_n_PM_14_25_12			2	0.4	5.90E-05	OAT, COL5A3, ABI3BP	collagen binding [MF], ornithine-oxo-acid transaminase activity [MF]
CG_adsipsc_promoter_n_PM_14_82_11			3	0.6	6.05E-05	EZH2, CDK11B, BST2, EAPP	cell proliferation [BP], regulation of cell proliferation [BP], negative regulation of transcription elongation from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_PM_12_79_8			5	0.6	2.72E-04	GBA2	glucosylceramide catabolic process [BP], glucosylceramidase activity [MF]
CG_adsipsc_promoter_n_PM_18_31_62			4	0.8	5.23E-05	CHD8, STRN4, AP3B2, CTNNBIP1, AP3B1	AP-3 adaptor complex [CC], armadillo repeat domain binding [MF]
CG_adsipsc_promoter_n_PM_12_214_13			2	0.4	7.37E-05	EARS2, SPPL2A, HLA-DPA1, NES, PHYH, OXER1	5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], positive regulation of intermediate filament depolymerization [BP], 5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], integral to lumenal side of endoplasmic reticulum membrane [CC], phytanoyl-CoA dioxygenase activity [MF], 5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], glutamate-tRNA(Gln) ligase activity [MF]
CG_adsipsc_promoter_n_PM_12_183_11			2	0.4	7.96E-06	GRIK3	adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway [BP]
CG_adsipsc_promoter_n_PM_20_36_98			1	0.2	7.09E-05	MED1, ATXN2, MTMR2, SCARB1	androgen biosynthetic process [BP], negative regulation of receptor internalization [BP]
CG_adsipsc_promoter_n_PM_12_210_10			2	0.4	1.18E-04	IFNGR1	interferon-gamma receptor activity [MF]
CG_adsipsc_promoter_n_PM_12_223_12			3	0.6	5.78E-05	CCBL2, SLC25A13	kynurenine-glyoxylate transaminase activity [MF], malate-aspartate shuttle [BP], cysteine-S-conjugate beta-lyase activity [MF]
CG_adsipsc_promoter_n_PM_14_11_18			3	0.4	9.38E-05	RFC1, CELSR1, RRN3, CSTF3, TRMT2B, TUT1, TP53	mRNA 3'-end processing [BP], mRNA polyadenylation [BP], protein localization involved in establishment of planar polarity [BP], S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [MF], nucleoplasm [CC], mRNA cleavage [BP], nucleotide-excision repair [BP], replication fork [CC]
CG_adsipsc_promoter_n_PM_12_106_7			1	0.2	1.07E-04	TMLHE	trimethyllysine dioxygenase activity [MF]
CG_adsipsc_promoter_n_PM_12_393_16			2	0.4	5.68E-05	ALDH9A1	4-trimethylammoniobutyraldehyde dehydrogenase activity [MF], aminobutyraldehyde dehydrogenase activity [MF], 1-pyrroline dehydrogenase activity [MF]
CG_adsipsc_promoter_n_PM_18_21_80			4	0.8	5.31E-05	STRBP, CPT1B, DICER1, PRKAG2, PIGU, ILF2, PGAP1	double-stranded RNA binding [MF], carnitine shuttle [BP], attachment of GPI anchor to protein [BP]
CG_adsipsc_promoter_n_PM_14_69_6			1	0.2	6.54E-05	SLC13A5, CDK5, MICU1, GIP, PIP5K1C	calcium ion import [BP], synaptic vesicle endocytosis [BP], succinate transmembrane transporter activity [MF], synaptic vesicle exocytosis [BP], positive regulation of glucagon secretion [BP], acetylcholine receptor activator activity [MF]
CG_adsipsc_promoter_n_PM_14_52_13			2	0.4	4.28E-05	HNF1B	regulation of pronephros size [BP]
CG_adsipsc_promoter_n_PM_16_39_17			2	0.4	5.63E-05	ST3GAL5, MEIS3, DRD3, FOXO1, PATZ1, HIRA	neolactotetraosylceramide alpha-2,3-sialyltransferase activity [MF], chromatin binding [MF], musculoskeletal movement, spinal reflex action [BP], lactosylceramide alpha-2,3-sialyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_16_28_14			4	0.8	6.64E-05	DDX17	RNA-dependent ATPase activity [MF]
CG_adsipsc_promoter_n_PM_12_366_12			1	0.2	1.61E-04	WDR92	histone lysine methylation [BP]
CG_adsipsc_promoter_n_PM_12_119_17			1	0.2	5.31E-05	CDK6	cell dedifferentiation [BP]
CG_adsipsc_promoter_n_PM_12_439_5			1	0.2	1.14E-04	CAPN6, LRP8, CTSS, DNPEP	proteolysis [BP], cysteine-type endopeptidase activity [MF], ammon gyrus development [BP]
CG_adsipsc_promoter_n_PM_16_5_14			4	0.8	6.75E-05	NIN, SNRPG, CPSF1, CYP51A1, DIMT1	termination of RNA polymerase II transcription [BP], 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [MF], sterol 14-demethylase activity [MF], cholesterol biosynthetic process via 24,25-dihydrolanosterol [BP], centrosome-templated microtubule nucleation [BP]
CG_adsipsc_promoter_n_PM_12_261_11			2	0.4	1.86E-04	BCHE, TBXA2R, ABHD15	carboxylesterase activity [MF], cocaine metabolic process [BP], thromboxane A2 receptor activity [MF]
CG_adsipsc_promoter_n_PM_14_53_32			5	0.8	5.70E-05	CTNNBIP1, MYLK3	regulation of vascular permeability involved in acute inflammatory response [BP]
CG_adsipsc_promoter_n_PM_12_435_7			1	0.2	8.88E-05	TNR	negative regulation of axon extension involved in regeneration [BP]
CG_adsipsc_promoter_n_PM_12_77_8			3	0.6	1.18E-04	AKR1B1, GNE, DBN1	glyceraldehyde oxidoreductase activity [MF], N-acylmannosamine kinase activity [MF], cell communication by chemical coupling [BP], UDP-N-acetylglucosamine 2-epimerase activity [MF]
CG_adsipsc_promoter_n_PM_12_432_12			1	0.2	4.30E-06	NSMCE1, FGF8, RECQL4	DNA recombination [BP], thyroid-stimulating hormone-secreting cell differentiation [BP], corticotropin hormone secreting cell differentiation [BP], cell migration involved in mesendoderm migration [BP], negative regulation of cardiac muscle tissue development [BP], mesodermal cell migration [BP], neuroepithelial cell differentiation [BP]
CG_adsipsc_promoter_n_PM_18_40_23			5	0.8	5.05E-05	DERL3, XBP1, SERP1	endoplasmic reticulum unfolded protein response [BP]
CG_adsipsc_promoter_n_PM_12_44_4			2	0.4	1.14E-04	KRT26, KRT71, COPB1	structural molecule activity [MF]
CG_adsipsc_promoter_n_PM_16_65_24			2	0.4	6.28E-05	PIF1, NTF4, A4GALT, CENPV	centromeric heterochromatin assembly [BP], ATP-dependent 5'-3' DNA/RNA helicase activity [MF], sensory organ boundary specification [BP], ganglion mother cell fate determination [BP], lactosylceramide 4-alpha-galactosyltransferase activity [MF], single-stranded DNA-dependent ATP-dependent DNA helicase activity [MF]
CG_adsipsc_promoter_n_PM_12_344_9			2	0.4	2.04E-04	AKIRIN2, C5, ADRA2B, SIN3A, CTBP2	transcriptional repressor complex [CC], negative regulation of norepinephrine secretion [BP]
CG_adsipsc_promoter_n_PM_14_66_19			3	0.6	4.43E-05	SLC12A6, PGM2L1	cellular hypotonic salinity response [BP], glucose-1,6-bisphosphate synthase activity [MF]
CG_adsipsc_promoter_n_PM_20_23_65			1	0.2	6.51E-05	MYH11, TAP2, HELQ, CKM, HSPA8, PRKDC, KIF17, DDX54, CER1, MESP1, XRCC2, SHPRH, NEK9, NCKAP1, DNA2, RAD54B, GDF3, NT5C, CETN2, CCT4, CDKL2, RUNX1, ICK, WNK3, MYH1, MCM3, IP6K1, SFRP2, TCP1, STK33, ABCC5, ATAD2B, MDN1	pyrimidine nucleotide binding [MF], cell migration involved in gastrulation [BP], helicase activity [MF], mesodermal cell migration [BP], mesoderm development [BP], negative regulation of mesodermal cell fate specification [BP], ATP binding [MF], nucleoside-triphosphatase activity [MF]
CG_adsipsc_promoter_n_PM_18_22_62			4	0.8	5.86E-05	POLQ, MCM7, RAD52, MED8, FANCL, TBL1XR1, STRN3	nucleoplasm [CC]
CG_adsipsc_promoter_n_PM_12_8_17			4	0.8	1.03E-04	PTGR1, AHI1	pronephric nephron tubule morphogenesis [BP], 2-alkenal reductase [NAD(P)] activity [MF], pronephric duct morphogenesis [BP], Kupffer's vesicle development [BP]
CG_adsipsc_promoter_n_PM_12_410_7			3	0.6	1.03E-04	SERPINA1, PPID, MVD, RPH3AL	response to methanol [BP], Hsp70 protein binding [MF], positive regulation of protein secretion [BP]
CG_adsipsc_promoter_n_PM_12_280_16			5	0.8	3.74E-04	ADAM8, TREH	trehalose metabolic process [BP], positive regulation of neutrophil extravasation [BP], positive regulation of fibronectin-dependent thymocyte migration [BP], alpha,alpha-trehalase activity [MF], dense core granule membrane [CC], alpha9-beta1 integrin-ADAM8 complex [CC], positive regulation of eosinophil migration [BP], trehalose catabolic process [BP]
CG_adsipsc_promoter_n_PM_12_157_16			2	0.4	1.26E-05	ROCK2	positive regulation of centrosome duplication [BP]
CG_adsipsc_promoter_n_PM_12_48_8			2	0.4	5.31E-05	INCA1, CIZ1	cyclin binding [MF], maintenance of nucleus location [BP]
CG_adsipsc_promoter_n_PM_12_371_11			2	0.4	2.78E-05	DLG4, C22orf28	RNA ligase (ATP) activity [MF], P2Y1 nucleotide receptor binding [MF]
CG_adsipsc_promoter_n_PM_12_203_15			2	0.4	1.46E-04	AHCY, ACTA1	skeletal muscle fiber adaptation [BP], adenosylhomocysteinase activity [MF]
CG_adsipsc_promoter_n_PM_16_33_91			5	1.0	4.79E-05	GIP	positive regulation of glucagon secretion [BP]
CG_adsipsc_promoter_n_PM_12_378_11			2	0.4	8.79E-06	GIPC1	endothelial cell migration [BP]
CG_adsipsc_promoter_n_PM_12_402_13			2	0.4	2.19E-04	TRMT5	tRNA (guanine(37)-N(1))-methyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_467_16			2	0.4	1.36E-04	DBN1, YBX2, MAD1L1	cell communication by chemical coupling [BP], mitotic telophase [BP], translational attenuation [BP]
CG_adsipsc_promoter_n_PM_20_21_180			2	0.2	5.17E-05	PABPC1, LEO1, GRSF1	mRNA polyadenylation [BP]
CG_adsipsc_promoter_n_PM_14_107_9			1	0.2	7.70E-06	SOX18	endocardium formation [BP], stem cell fate specification [BP]
CG_adsipsc_promoter_n_PM_20_34_60			2	0.2	4.34E-05	OXTR, INPP5K	vasopressin receptor activity [MF]
CG_adsipsc_promoter_n_PM_12_205_7			1	0.2	1.65E-04	CELSR1, AP3D1	protein localization involved in establishment of planar polarity [BP], lateral sprouting involved in lung morphogenesis [BP], establishment of body hair planar orientation [BP], antigen processing and presentation, exogenous lipid antigen via MHC class Ib [BP], orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [BP], planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [BP], synaptic vesicle membrane organization [BP]
CG_adsipsc_promoter_n_PM_14_68_26			4	0.8	5.57E-05	SLC38A7, ALAD, PLOD3	L-leucine transmembrane transporter activity [MF], procollagen glucosyltransferase activity [MF], porphobilinogen synthase activity [MF], L-methionine transmembrane transporter activity [MF], lead ion binding [MF]
CG_adsipsc_promoter_n_PM_12_12_8			2	0.4	1.60E-04	SLC17A7, KAT6A, NAT9	sequestering of neurotransmitter [BP], acetyltransferase activity [MF], N-acetyltransferase activity [MF], sodium:inorganic phosphate symporter activity [MF]
CG_adsipsc_promoter_n_PM_12_59_12			2	0.4	1.93E-04	SNTA1	regulation of vasoconstriction by circulating norepinephrine [BP]
CG_adsipsc_promoter_n_PM_12_417_22			4	0.8	2.12E-05	MAML2, LMO2, TARBP1, SMAD2, UNC13D, SLC25A29, FOXP1	granuloma formation [BP], activating transcription factor binding [MF], positive regulation of transcription from RNA polymerase II promoter [BP], acyl carnitine transmembrane transporter activity [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_PM_12_168_17			1	0.2	5.66E-05	ASTL, UFSP1	glutamic-type peptidase activity [MF], UFM1 hydrolase activity [MF], cortical granule [CC]
CG_adsipsc_promoter_n_PM_18_28_36			4	0.8	3.21E-05	TFRC	transferrin receptor activity [MF]
CG_adsipsc_promoter_n_PM_12_276_16			4	0.6	3.03E-05	SPTLC1, NCBP2	SPOTS complex [CC], sphinganine biosynthetic process [BP], positive regulation of RNA export from nucleus [BP], snRNA export from nucleus [BP]
CG_adsipsc_promoter_n_PM_12_110_12			2	0.4	9.96E-05	CEBPA, EARS2, TK1, EXOSC10	glutamate-tRNA(Gln) ligase activity [MF], nuclear retention of unspliced pre-mRNA at the site of transcription [BP], response to vitamin B2 [BP], fetal process involved in parturition [BP]
CG_adsipsc_promoter_n_PM_12_179_12			2	0.4	6.36E-05	MUSTN1, NINJ1	tissue regeneration [BP]
CG_adsipsc_promoter_n_PM_12_164_17			2	0.4	9.96E-05	HEY1, KDM5B	atrioventricular valve formation [BP], histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP], histone demethylase activity (H3-trimethyl-K4 specific) [MF], negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [BP], umbilical cord morphogenesis [BP]
CG_adsipsc_promoter_n_PM_12_265_11			3	0.6	3.66E-04	TGFB3	frontal suture morphogenesis [BP], ossification involved in bone remodeling [BP], embryonic neurocranium morphogenesis [BP], negative regulation of macrophage cytokine production [BP], detection of hypoxia [BP]
CG_adsipsc_promoter_n_PM_14_14_20			7	1.0	9.26E-05	ABCB6	heme-transporting ATPase activity [MF]
CG_adsipsc_promoter_n_PM_12_40_11			3	0.6	1.14E-04	SIAE	sialate O-acetylesterase activity [MF]
CG_adsipsc_promoter_n_PM_12_384_4			1	0.2	6.76E-05	ALKBH1	RNA repair [BP]
CG_adsipsc_promoter_n_PM_14_110_16			3	0.6	4.68E-05	NACA, VIMP	regulation of nitric oxide metabolic process [BP], negative regulation of transcription from RNA polymerase II promoter involved in heart development [BP], positive regulation of skeletal muscle tissue growth [BP], nascent polypeptide-associated complex [CC]
CG_adsipsc_promoter_n_PM_20_20_81			2	0.2	3.66E-05	DHFRL1	tetrahydrofolate biosynthetic process [BP], thymidine biosynthetic process [BP], dihydrofolate reductase activity [MF]
CG_adsipsc_promoter_n_PM_14_103_8			2	0.4	3.28E-05	FOXM1, ARHGEF3, RASGRP4, ARHGDIA, MAPKAP1	Ras guanyl-nucleotide exchange factor activity [MF], nerve growth factor receptor signaling pathway [BP], regulation of Ras protein signal transduction [BP], small GTPase mediated signal transduction [BP], regulation of small GTPase mediated signal transduction [BP], transmembrane receptor protein tyrosine kinase signaling pathway [BP]
CG_adsipsc_promoter_n_PM_12_14_4			2	0.4	9.73E-06	SOCS3, PSME2	proteasome activator complex [CC], spongiotrophoblast differentiation [BP]
CG_adsipsc_promoter_n_PM_14_30_14			2	0.4	7.59E-05	LBX1	regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP]
CG_adsipsc_promoter_n_PM_12_162_17			2	0.4	2.80E-05	SPTB, RUVBL1, ACTB	actin filament capping [BP], NuA4 histone acetyltransferase complex [CC]
CG_adsipsc_promoter_n_PM_12_244_9			1	0.2	2.65E-05	ARSA	cerebroside-sulfatase activity [MF]
CG_adsipsc_promoter_n_PM_12_285_9			3	0.6	1.51E-04	CDIP1, STK24, EDN2, NME3, C22orf29	positive regulation of smooth muscle contraction [BP], induction of apoptosis [BP]
CG_adsipsc_promoter_n_PM_12_83_9			5	0.8	2.60E-05	PEMT, CHIT1	phosphatidylethanolamine N-methyltransferase activity [MF], endochitinase activity [MF], phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [MF], phosphatidyl-N-methylethanolamine N-methyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_14_99_16			6	1.0	4.69E-05	RELA, IL5, GANAB, MUL1, UBXN7	acetaldehyde metabolic process [BP], ubiquitin protein ligase binding [MF], positive regulation of eosinophil differentiation [BP], glucosidase II complex [CC], glucan 1,3-alpha-glucosidase activity [MF]
CG_adsipsc_promoter_n_PM_12_177_13			2	0.4	7.24E-05	VARS, MAD2L2	valyl-tRNA aminoacylation [BP], valine-tRNA ligase activity [MF], zeta DNA polymerase complex [CC]
CG_adsipsc_promoter_n_PM_12_471_13			6	1.0	9.43E-06	PC, MGAT1	pyruvate carboxylase activity [MF], alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], UDP-N-acetylglucosamine catabolic process [BP]
CG_adsipsc_promoter_n_PM_16_32_33			4	0.8	4.42E-05	PDGFB, AKIRIN2, HRAS, AVP, RPS15A, CRYM, LIFR, CACUL1, FLT3, CTSH	positive regulation of cell proliferation [BP], thyroid hormone binding [MF]
CG_adsipsc_promoter_n_PM_12_278_15			2	0.4	7.08E-05	SLC36A2	proline transmembrane transport [BP], hydrogen:amino acid symporter activity [MF]
CG_adsipsc_promoter_n_PM_12_166_12			1	0.2	2.60E-04	PSIP1, KCNJ1	regulation of G-protein activated inward rectifier potassium channel activity [BP], supercoiled DNA binding [MF]
CG_adsipsc_promoter_n_PM_12_74_8			2	0.4	1.87E-04	OCA2, AXIN1	arsenite transport [BP], protein complex scaffold [MF], tyrosine transport [BP], L-tyrosine transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_PM_12_281_9			2	0.4	1.03E-04	RAPGEF1, COL4A1, PDGFA, FOXP3	platelet-derived growth factor binding [MF], platelet-derived growth factor receptor signaling pathway [BP], positive regulation of peripheral T cell tolerance induction [BP], negative regulation of immune response [BP], regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP]
CG_adsipsc_promoter_n_PM_12_263_8			1	0.2	5.25E-05	ABCA4	phospholipid transfer to membrane [BP]
CG_adsipsc_promoter_n_PM_14_41_4			1	0.2	2.63E-05	TLE2, CAMK2G, CIB1, CTDSP2, XPC	nucleoplasm [CC]
CG_adsipsc_promoter_n_PM_12_78_9			2	0.4	1.66E-04	IFNG, GCH1, TCF15, NEUROG1, GPCPD1, LBX1	nitric oxide metabolic process [BP], nitric oxide biosynthetic process [BP], glycerophosphocholine phosphodiesterase activity [MF], cellular response to interleukin-18 [BP], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP], positive regulation of neuron differentiation [BP], neuromuscular process controlling posture [BP], positive regulation of fructose 1,6-bisphosphate metabolic process [BP], GTP cyclohydrolase I activity [MF], positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity [BP], 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_12_53_16			2	0.4	2.26E-04	HDDC3, TMED10, HNF1B	guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF], regulation of pronephros size [BP], regulated secretory pathway [BP]
CG_adsipsc_promoter_n_PM_12_453_12			1	0.2	5.16E-05	GIP, SMARCA1	nucleosome-dependent ATPase activity [MF], positive regulation of glucagon secretion [BP]
CG_adsipsc_promoter_n_PM_14_45_8			2	0.4	3.50E-05	DUSP1, ADAM8, SDF4	positive regulation of fibronectin-dependent thymocyte migration [BP], alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex [CC], positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [BP], activation of MAPK activity involved in innate immune response [BP], positive regulation of neutrophil extravasation [BP], zymogen granule exocytosis [BP], response to light stimulus [BP], dense core granule membrane [CC], alpha9-beta1 integrin-ADAM8 complex [CC], positive regulation of eosinophil migration [BP]
CG_adsipsc_promoter_n_PM_12_140_8			3	0.6	2.07E-04	FBXW7, LTN1	negative regulation of hepatocyte proliferation [BP], protein ubiquitination [BP], negative regulation of triglyceride biosynthetic process [BP], negative regulation of SREBP signaling pathway [BP]
CG_adsipsc_promoter_n_PM_16_46_13			4	0.8	3.49E-05	B4GALT6	galactosyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_20_8_101			1	0.2	5.21E-05	NUP62, SLC9A1, MANBA, GYS1, MGAT1, DPM3, HAS1, B4GALNT1, TREH	carbohydrate metabolic process [BP]
CG_adsipsc_promoter_n_PM_12_446_10			1	0.2	1.29E-05	LPCAT1	negative regulation of phosphatidylcholine biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_12_28_14			3	0.6	3.48E-05	UROC1	urocanate hydratase activity [MF], histidine catabolic process to glutamate and formamide [BP], histidine catabolic process [BP], histidine catabolic process to glutamate and formate [BP]
CG_adsipsc_promoter_n_PM_18_24_13			1	0.2	3.87E-05	PYCARD	positive regulation of antigen processing and presentation of peptide antigen via MHC class II [BP], positive regulation of interleukin-10 secretion [BP], positive regulation of chemokine secretion [BP], positive regulation of interleukin-8 secretion [BP], Pyrin domain binding [MF], NLRP1 inflammasome complex [CC], myeloid dendritic cell activation involved in immune response [BP], macropinocytosis [BP], NLRP3 inflammasome complex [CC], negative regulation of interferon-beta production [BP], positive regulation of interleukin-6 secretion [BP], AIM2 inflammasome complex [CC]
CG_adsipsc_promoter_n_PM_12_46_15			1	0.2	1.62E-04	CBS	cysteine biosynthetic process via cystathionine [BP], cystathionine beta-synthase activity [MF], cysteine biosynthetic process from serine [BP], homocysteine catabolic process [BP]
CG_adsipsc_promoter_n_PM_12_328_21			2	0.4	5.16E-05	TMEM48	nuclear pore distribution [BP]
CG_adsipsc_promoter_n_PM_12_107_7			2	0.4	1.48E-04	PGAM2	2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [MF]
CG_adsipsc_promoter_n_PM_12_13_12			2	0.4	4.02E-06	GPR18, OXGR1	G-protein coupled purinergic nucleotide receptor activity [MF]
CG_adsipsc_promoter_n_PM_12_184_8			4	0.6	1.29E-04	CHUK	IkappaB kinase activity [MF]
CG_adsipsc_promoter_n_PM_14_74_18			4	0.8	1.93E-05	ITPK1, GNPTAB	inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_adsipsc_promoter_n_PM_14_47_9			2	0.4	2.06E-05	RHOA	regulation of calcium ion transport [BP]
CG_adsipsc_promoter_n_PM_12_114_10			4	0.6	7.44E-05	FH, TOPORS, FOPNL	fumarate hydratase activity [MF], microtubule basal body [CC], DNA topoisomerase binding [MF]
CG_adsipsc_promoter_n_PM_12_317_7			3	0.6	3.16E-05	MLXIPL	glucose mediated signaling pathway [BP], carbohydrate response element binding [MF]
CG_adsipsc_promoter_n_PM_12_313_9			3	0.6	1.26E-04	NR5A1, NLRP12, SLC16A8	negative regulation of Toll signaling pathway [BP], lactate transport [BP], lactate transmembrane transport [BP], regulation of interleukin-18 biosynthetic process [BP], lactate transmembrane transporter activity [MF], multicellular organismal aging [BP]
CG_adsipsc_promoter_n_PM_12_186_6			2	0.4	1.59E-04	GAMT, TRPM1, HTR2B, UNC13D	guanidinoacetate N-methyltransferase activity [MF], muscle contraction [BP], granuloma formation [BP], calcium ion transmembrane transport [BP]
CG_adsipsc_promoter_n_PM_16_49_34			3	0.6	3.32E-05	FIS1, SIAH2, SH3RF1, LPHN1	calcium-mediated signaling using intracellular calcium source [BP], negative regulation of extrinsic apoptotic signaling pathway [BP]
CG_adsipsc_promoter_n_PM_12_310_11			3	0.6	2.08E-04	FUZ, DLC1	neural tube closure [BP]
CG_adsipsc_promoter_n_PM_18_16_41			3	0.6	4.05E-05	USMG5, ATP6V1H, ATP5B	proton-transporting ATPase activity, rotational mechanism [MF], mitochondrial proton-transporting ATP synthase complex [CC]
CG_adsipsc_promoter_n_PM_12_88_14			3	0.6	4.30E-05	TFF2, NUMB, DLK2, SARDH	sarcosine dehydrogenase activity [MF], CXCR4 chemokine receptor binding [MF], negative regulation of Notch signaling pathway [BP]
CG_adsipsc_promoter_n_PM_12_173_15			3	0.6	8.79E-05	ARRDC3, STK3	negative regulation of heat generation [BP], hippo signaling cascade [BP], negative regulation of locomotion involved in locomotory behavior [BP]
CG_adsipsc_promoter_n_PM_12_126_6			2	0.4	1.10E-04	DDX60	positive regulation of MDA-5 signaling pathway [BP]
CG_adsipsc_promoter_n_PM_12_72_6			1	0.2	9.03E-05	CNR2	negative regulation of action potential [BP]
CG_adsipsc_promoter_n_PM_14_76_15			2	0.4	6.12E-05	CHRNA10, POLE, EZH2, ATP5B, CDK2AP1, ASTL	glutamic-type peptidase activity [MF], cortical granule [CC], S phase of mitotic cell cycle [BP], synaptic transmission, cholinergic [BP], mitochondrial proton-transporting ATP synthase, catalytic core [CC]
CG_adsipsc_promoter_n_PM_12_146_22			2	0.4	2.74E-05	EPB41L2, FLOT1, MEX3D	mRNA localization resulting in posttranscriptional regulation of gene expression [BP], signalosome [CC]
CG_adsipsc_promoter_n_PM_12_120_5			2	0.4	1.37E-04	CHCHD4	protein import into mitochondrial intermembrane space [BP]
CG_adsipsc_promoter_n_PM_20_33_175			1	0.2	4.35E-05	DOC2B, SP3, EIF3E, AKT2, NR2C1, NFE2, AP3D1, CHEK2, AP3B1	positive regulation of vesicle fusion [BP], PML body [CC], antigen processing and presentation, exogenous lipid antigen via MHC class Ib [BP], positive regulation of NK T cell differentiation [BP]
CG_adsipsc_promoter_n_PM_12_41_6			2	0.4	2.67E-04	ATE1	arginyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_312_13			2	0.4	1.24E-04	SMPX	muscle tendon junction [CC]
CG_adsipsc_promoter_n_PM_12_254_15			3	0.4	1.26E-04	CASQ2, TNR, NOS1	negative regulation of axon extension involved in regeneration [BP], regulation of cardiac muscle contraction [BP], sarcoplasmic reticulum [CC]
CG_adsipsc_promoter_n_PM_12_45_5			1	0.2	6.60E-05	MEN1, NEFL	positive regulation of protein binding [BP], neurofilament bundle assembly [BP]
CG_adsipsc_promoter_n_PM_12_440_8			2	0.4	1.04E-04	PCYT1A, MTSS1, EOMES	mesodermal to mesenchymal transition involved in gastrulation [BP], epithelial cell proliferation involved in renal tubule morphogenesis [BP], CD8-positive, alpha-beta T cell differentiation involved in immune response [BP], choline-phosphate cytidylyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_319_7			1	0.2	1.43E-05	SEPT12, CARD17, BNIP3, CASP4	cellular response to cobalt ion [BP], cysteine-type endopeptidase activity [MF], sperm annulus [CC]
CG_adsipsc_promoter_n_PM_12_155_15			4	0.8	1.49E-04	ARRB1, PIP4K2B, SERPINB9	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [MF], receptor signaling protein activity [MF]
CG_adsipsc_promoter_n_PM_16_11_18			2	0.4	5.29E-05	SCARB1, EZR, TGM2	microvillus membrane [CC], apoptotic cell clearance [BP]
CG_adsipsc_promoter_n_PM_12_93_16			2	0.4	3.13E-04	MMAB, HCAR2	nicotinic acid receptor activity [MF], cob(I)yrinic acid a,c-diamide adenosyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_314_12			3	0.6	2.46E-04	GPR55, FOXJ1	negative regulation of germinal center formation [BP], central tolerance induction [BP], cannabinoid signaling pathway [BP], negative regulation of humoral immune response mediated by circulating immunoglobulin [BP], glomerular parietal epithelial cell development [BP], positive regulation of lung ciliated cell differentiation [BP], positive regulation of central B cell tolerance induction [BP]
CG_adsipsc_promoter_n_PM_12_234_8			1	0.2	8.27E-05	WAPAL, PKD1L3, NAE1	NEDD8 activating enzyme activity [MF], detection of chemical stimulus involved in sensory perception of sour taste [BP], negative regulation of sister chromatid cohesion [BP], sour taste receptor activity [MF]
CG_adsipsc_promoter_n_PM_12_90_14			3	0.6	1.66E-04	ADAMTS8	low affinity phosphate transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_PM_12_81_19			2	0.4	2.91E-05	SLC7A10	D-serine transport [BP], D-alanine transport [BP], L-serine transport [BP]
CG_adsipsc_promoter_n_PM_18_36_22			4	0.8	7.62E-05	COG4, COG7	Golgi transport complex [CC]
CG_adsipsc_promoter_n_PM_12_339_9			3	0.6	1.48E-04	OPLAH	5-oxoprolinase (ATP-hydrolyzing) activity [MF]
CG_adsipsc_promoter_n_PM_12_465_14			2	0.4	1.35E-05	ANKLE2, SMG5	protein phosphatase 2A binding [MF]
CG_adsipsc_promoter_n_PM_12_19_26			5	0.8	7.46E-05	PTK2, PTRH2	negative regulation of anoikis [BP]
CG_adsipsc_promoter_n_PM_14_111_25			7	1.0	6.96E-05	ST8SIA5	glycosphingolipid biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_18_7_24			1	0.2	2.72E-05	SSR1, RPL23, RPS29, RPS13	cotranslational protein targeting to membrane [BP], SRP-dependent cotranslational protein targeting to membrane [BP]
CG_adsipsc_promoter_n_PM_16_2_71			6	1.0	5.13E-05	APOD, ANXA5, TRIM17, KRBA2, TRIM64C, HVCN1, SNTA1, ARHGEF39, TLR10, EXD3, ZNF598, TBC1D28, NINJ2, NOX1	intracellular [CC], tissue regeneration [BP], voltage-gated proton channel activity [MF]
CG_adsipsc_promoter_n_PM_12_49_8			2	0.4	3.50E-05	SLC6A15, CCL23	proline:sodium symporter activity [MF], negative regulation of C-C chemokine binding [BP]
CG_adsipsc_promoter_n_PM_14_104_8			1	0.2	8.00E-06	AKAP8L	DEAD/H-box RNA helicase binding [MF]
CG_adsipsc_promoter_n_PM_12_429_11			2	0.4	5.98E-05	ALAD, OXER1	5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], 5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], 5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], porphobilinogen synthase activity [MF], lead ion binding [MF]
CG_adsipsc_promoter_n_PM_12_73_10			2	0.4	9.45E-05	AIPL1, DUOX2	farnesylated protein binding [MF], protein farnesylation [BP], cuticle development [BP], adenohypophysis morphogenesis [BP]
CG_adsipsc_promoter_n_PM_12_302_23			3	0.4	1.23E-05	BUD13	RES complex [CC]
CG_adsipsc_promoter_n_PM_14_15_37			7	1.0	6.15E-05	CTSH, CASP3, KCNC3, CACNA1A, BAG5, GHRL, CLCF1, TNFRSF25, PHB, RAF1, ATXN3, COMP, BCL2L1	neuron death [BP], cell death [BP], negative regulation of apoptotic process [BP], regulation of apoptotic process [BP]
CG_adsipsc_promoter_n_PM_14_106_5			1	0.2	1.49E-04	CRH, ENAH, WNT7B, MYH10	stress fiber [CC], establishment or maintenance of polarity of embryonic epithelium [BP], corticotropin-releasing hormone activity [MF], ferulate metabolic process [BP], outer medullary collecting duct development [BP]
CG_adsipsc_promoter_n_PM_18_25_36			4	0.8	3.96E-05	SHPK, FTSJ2	cellular response to interleukin-13 [BP], regulation of inflammatory response [BP], rRNA methylation [BP]
CG_adsipsc_promoter_n_PM_12_403_22			2	0.4	1.68E-04	GP5, DEGS2, CERS3, PDGFB	negative regulation of platelet activation [BP], phospholipid metabolic process [BP]
CG_adsipsc_promoter_n_PM_12_421_5			2	0.4	3.43E-04	FGF8	cell migration involved in mesendoderm migration [BP]
CG_adsipsc_promoter_n_PM_12_479_10			2	0.4	2.92E-05	PKD1	metanephric distal tubule morphogenesis [BP], polycystin complex [CC]
CG_adsipsc_promoter_n_PM_14_81_13			2	0.4	2.21E-05	WNT7B, STMN1	outer medullary collecting duct development [BP], establishment or maintenance of polarity of embryonic epithelium [BP], renal inner medulla development [BP], inner medullary collecting duct development [BP], renal outer medulla development [BP], intracellular signal transduction [BP]
CG_adsipsc_promoter_n_PM_14_100_9			1	0.2	7.93E-05	COL11A2, DIMT1	collagen type XI [CC], 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_18_35_34			4	0.8	2.29E-05	AFAP1, SRCIN1, BAIAP2L1	actin cytoskeleton [CC]
CG_adsipsc_promoter_n_PM_14_12_14			1	0.2	2.19E-05	PLD6	cardiolipin hydrolase activity [MF]
CG_adsipsc_promoter_n_PM_12_352_14			2	0.4	1.26E-04	P2RX1	external side of cell outer membrane [CC], protein heterooligomerization [BP]
CG_adsipsc_promoter_n_PM_12_390_10			3	0.6	1.85E-04	LIF, POLG2, MUT	methylmalonyl-CoA mutase activity [MF], positive regulation of histone H3-K27 acetylation [BP], RNA polymerase II transcription factor recruiting transcription factor activity [MF], positive regulation of protein localization to nucleus [BP], mitochondrial chromosome [CC]
CG_adsipsc_promoter_n_PM_12_259_16			3	0.4	1.85E-05	XPO1	annulate lamellae [CC]
CG_adsipsc_promoter_n_PM_12_335_6			1	0.2	2.76E-04	MPC2	pyruvate transmembrane transporter activity [MF], mitochondrial pyruvate transport [BP]
CG_adsipsc_promoter_n_PM_12_248_10			1	0.2	4.67E-04	PPP3CB, SYCP3, RAG2	spermatogenesis, exchange of chromosomal proteins [BP], B cell homeostatic proliferation [BP], calcineurin complex [CC]
CG_adsipsc_promoter_n_PM_14_102_7			2	0.4	2.75E-05	CSGALNACT1	peptidoglycan glycosyltransferase activity [MF], glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_16_27_17			4	0.8	4.10E-05	WDR4, RFWD2, MKNK2, PSMA1, CDC23, UROS, TAF11, SMURF2, SMARCE1, GIT2, BRF2, ANAPC7, SMARCC1	npBAF complex [CC], cellular response to arsenic-containing substance [BP], nucleoplasm [CC], nBAF complex [CC]
CG_adsipsc_promoter_n_PM_12_294_13			4	0.8	3.12E-05	CCBL1	L-phenylalanine:pyruvate aminotransferase activity [MF], L-phenylalanine-oxaloacetate transaminase activity [MF], glutamine-phenylpyruvate transaminase activity [MF], L-glutamine:pyruvate aminotransferase activity [MF], L-kynurenine catabolic process [BP]
CG_adsipsc_promoter_n_PM_12_311_20			2	0.4	2.83E-05	HTR2A, LIF	phospholipase C-activating serotonin receptor signaling pathway [BP], positive regulation of histone H3-K27 acetylation [BP], RNA polymerase II transcription factor recruiting transcription factor activity [MF], positive regulation of protein localization to nucleus [BP]
CG_adsipsc_promoter_n_PM_12_144_17			3	0.6	1.09E-04	UBA3, MATN1	NEDD8 activating enzyme activity [MF], growth plate cartilage chondrocyte morphogenesis [BP]
CG_adsipsc_promoter_n_PM_12_4_10			2	0.4	1.72E-04	HCN4	sodium channel activity [MF]
CG_adsipsc_promoter_n_PM_14_51_12			2	0.4	3.04E-05	HERPUD2, PARP16	response to unfolded protein [BP]
CG_adsipsc_promoter_n_PM_14_90_17			3	0.6	2.68E-04	SLC25A2	mitochondrial ornithine transport [BP], L-ornithine transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_PM_12_216_7			3	0.6	1.60E-04	ADAM8, MTMR2	alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex [CC], positive regulation of early endosome to late endosome transport [BP], positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [BP], dendritic spine maintenance [BP], positive regulation of neutrophil extravasation [BP], negative regulation of receptor catabolic process [BP], positive regulation of fibronectin-dependent thymocyte migration [BP], activation of MAPK activity involved in innate immune response [BP], dense core granule membrane [CC], alpha9-beta1 integrin-ADAM8 complex [CC], positive regulation of eosinophil migration [BP]
CG_adsipsc_promoter_n_PM_12_238_8			3	0.6	1.26E-05	SLC9A1	sodium ion export [BP]
CG_adsipsc_promoter_n_PM_14_16_7			2	0.4	1.49E-04	ST3GAL5, TMEM86B	neolactotetraosylceramide alpha-2,3-sialyltransferase activity [MF], lactosylceramide alpha-2,3-sialyltransferase activity [MF], alkenylglycerophosphocholine hydrolase activity [MF], alkenylglycerophosphoethanolamine hydrolase activity [MF]
CG_adsipsc_promoter_n_PM_12_370_9			2	0.4	2.07E-04	SLC2A2	hexose transmembrane transport [BP]
CG_adsipsc_promoter_n_PM_14_94_12			4	0.8	8.60E-05	RPS6KA5, SLC17A5, ADRA1D, TFRC, CNPY2, PTPRH, BRCA1	integral to plasma membrane [CC], positive regulation of histone acetylation [BP]
CG_adsipsc_promoter_n_PM_12_480_16			2	0.4	3.18E-04	EHD1, TICAM1	endosome membrane [CC]
CG_adsipsc_promoter_n_PM_12_247_13			1	0.2	9.15E-05	HYI, FDXR	hydroxypyruvate isomerase activity [MF], NADPH-adrenodoxin reductase activity [MF], ferredoxin-NADP+ reductase activity [MF]
CG_adsipsc_promoter_n_PM_12_374_6			2	0.4	3.10E-05	BCAT1, PLSCR1, SERPINE2	L-leucine transaminase activity [MF], branched-chain-amino-acid transaminase activity [MF], positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [BP], L-isoleucine transaminase activity [MF], seminal vesicle epithelium development [BP], mating plug formation [BP], branched-chain amino acid biosynthetic process [BP], L-valine transaminase activity [MF]
CG_adsipsc_promoter_n_PM_12_475_13			2	0.4	3.28E-04	HVCN1, BAZ1B	vitamin D receptor activator activity [MF], DNA replication-dependent nucleosome disassembly [BP], voltage-gated proton channel activity [MF]
CG_adsipsc_promoter_n_PM_14_108_18			5	0.8	5.60E-05	SLBP, IP6K2, ITPKB	DNA replication involved in S phase [BP], inositol-1,4,5-trisphosphate 3-kinase activity [MF]
CG_adsipsc_promoter_n_PM_12_91_22			3	0.6	2.50E-04	SLC25A1	mitochondrial citrate transport [BP]
CG_adsipsc_promoter_n_PM_20_6_108			1	0.2	4.48E-05	TRAPPC8, THEM4, SCAMP2, TIPIN, FAM3C, CYP39A1, IER3IP1, MTOR, RAB43, ZDHHC21, GUSB, LMAN2L, GOLM1, AP3B1	Golgi apparatus [CC], endomembrane system [CC], intracellular membrane-bounded organelle [CC]
CG_adsipsc_promoter_n_PM_12_351_9			3	0.6	9.28E-05	MGLL, MMS19, FLNA	Fc-gamma receptor I complex binding [MF], regulation of endocannabinoid signaling pathway [BP], Myb complex [CC], phosphorelay signal transduction system [BP]
CG_adsipsc_promoter_n_PM_20_7_86			1	0.2	4.56E-05	BPIFC, SNRPD2, GEMIN5, SCARB1	spliceosomal snRNP assembly [BP], lipopolysaccharide binding [MF]
CG_adsipsc_promoter_n_PM_12_349_10			3	0.6	8.49E-06	TBXA2R, CRYM	thyroid hormone transport [BP], thiomorpholine-carboxylate dehydrogenase activity [MF], thromboxane A2 receptor activity [MF]
CG_adsipsc_promoter_n_PM_12_171_8			1	0.2	2.01E-04	MAP4K1	MAP kinase kinase kinase kinase activity [MF]
CG_adsipsc_promoter_n_PM_12_450_10			2	0.4	1.65E-04	HPD, LAMP3	4-hydroxyphenylpyruvate dioxygenase activity [MF], alveolar lamellar body membrane [CC]
CG_adsipsc_promoter_n_PM_12_249_6			2	0.4	1.22E-04	EIF2S2, IRX4, MTERF	termination of mitochondrial transcription [BP], establishment of organ orientation [BP], eukaryotic translation initiation factor 2 complex [CC]
CG_adsipsc_promoter_n_PM_12_298_20			2	0.4	3.11E-05	APOB, SUMO1	mature chylomicron [CC], chylomicron remnant [CC], protein localization to nuclear pore [BP]
CG_adsipsc_promoter_n_PM_12_296_16			3	0.6	4.41E-05	PIK3IP1, FOXP3	negative regulation of phosphatidylinositol 3-kinase activity [BP], positive regulation of peripheral T cell tolerance induction [BP], phosphatidylinositol 3-kinase catalytic subunit binding [MF]
CG_adsipsc_promoter_n_PM_12_422_6			2	0.4	1.94E-05	ISYNA1	inositol-3-phosphate synthase activity [MF]
CG_adsipsc_promoter_n_PM_12_185_9			4	0.6	4.15E-05	TXN	response to thyroxine stimulus [BP]
CG_adsipsc_promoter_n_PM_12_228_11			3	0.6	1.16E-04	MB	slow-twitch skeletal muscle fiber contraction [BP]
CG_adsipsc_promoter_n_PM_20_32_54			1	0.2	2.83E-05	CLPB, MKI67	cellular response to heat [BP]
CG_adsipsc_promoter_n_PM_12_478_6			1	0.2	9.54E-06	STAR, BAIAP2L2	response to fungicide [BP], fractalkine metabolic process [BP], cellular response to epinephrine stimulus [BP], cellular response to luteinizing hormone stimulus [BP], clathrin complex [CC], insecticide metabolic process [BP]
CG_adsipsc_promoter_n_PM_12_25_4			2	0.4	1.24E-04	GJA5, TRERF1, SYCP3, PRLR	prolactin signaling pathway [BP], spermatogenesis, exchange of chromosomal proteins [BP], steroid biosynthetic process [BP], AV node cell to bundle of His cell communication by electrical coupling [BP], atrial ventricular junction remodeling [BP]
CG_adsipsc_promoter_n_PM_12_449_7			2	0.4	3.90E-05	SORBS2, KRT16	structural constituent of cytoskeleton [MF]
CG_adsipsc_promoter_n_PM_12_233_13			3	0.6	1.16E-04	OCA2, HRAS	arsenite transport [BP], L-tyrosine transmembrane transporter activity [MF], tyrosine transport [BP], positive regulation of ruffle assembly [BP]
CG_adsipsc_promoter_n_PM_16_1_143			6	1.0	6.39E-05	RPL26, LYPLA1, NQO1, HPS5, CHMP2A, RAPGEF1, GDI2, S100A16, NOSIP, SMG1, DPP9, CLINT1, MTMR6, PYGM, CUL2, C2CD2, IARS, CTNNAL1, DIAPH3, ZFP106, RPL12, GMIP, DICER1, CSNK2A2, PCYT1A, PSRC1, EEF1G, GRB14, CEP70, KPNA1, ACLY, DPP7, STRADA, ARHGAP18, NSL1, SLBP, HSD17B14, HRAS, ALDH3A1, TRIM37, ARHGAP9, DCP1A, FAM13A, PPM1F, CCT8, SMURF2, CUBN, PIK3R3, JAK3, ARHGAP12, ITPK1, CLNS1A, STAT6, CDC25A, HERC1, TP53INP1, ANAPC1, ANAPC5, STAT2, CABP5, CDC23, PSMD12, ATP6V1G3, PLEC, GFPT2, ACP5, ERCC6L, PI4KB, AMPD1, SMAD7, CNBP, DIABLO, FABP1, PIK3AP1, OSTM1, SEC23A, RACGAP1, TEC, ETF1, GEMIN4, HNRNPD, CISH, FGD1, CARS, SNUPN, CEP41, SULT1A2, ALDH9A1, CNOT6L, VPS35, SOS1, PIP5K1C, ATP6V1E1, PAIP1, STAT5B, PRKACG, MYO9A, TUBGCP2, RILPL2, ST13, MCM3AP, VARS, ARHGEF11, BBC3, OPLAH, LPIN2, DPYD, BID, SPAG9, SPTBN2, CDCA3, PHOSPHO1, PYCARD, CNOT1, NT5C3, YWHAE, ICK, COPE, MLXIPL, PYDC1, ABR, PLA2G4C, RCC2, AARS, RPL30, NOTCH3, ARHGAP32, PTRF, ARHGAP39, TLE1, PGM2L1	DNA replication involved in S phase [BP], cytosol [CC]
CG_adsipsc_promoter_n_PM_12_357_8			1	0.2	9.62E-05	PRKAG2, ACADL, TPT1, OPRK1	response to virus [BP], regulation of fatty acid biosynthetic process [BP], carnitine catabolic process [BP], dynorphin receptor activity [MF], regulation of fatty acid oxidation [BP], negative regulation of ectoderm development [BP]
CG_adsipsc_promoter_n_PM_12_425_9			3	0.6	8.62E-05	XPNPEP1	metalloaminopeptidase activity [MF]
CG_adsipsc_promoter_n_PM_20_11_90			1	0.2	5.01E-05	AQP3, HRAS, ALS2, SLC4A7, SLC4A1, SLC29A2, MAP4K2	positive regulation of Rac protein signal transduction [BP], basolateral plasma membrane [CC]
CG_adsipsc_promoter_n_PM_12_159_13			4	0.8	1.71E-04	RPS6KA3, MLKL, SLC8A1	sodium ion export [BP], protein kinase activity [MF]
CG_adsipsc_promoter_n_PM_12_189_11			1	0.2	9.44E-05	PCDH15, C2orf71	photoreceptor outer segment [CC]
CG_adsipsc_promoter_n_PM_12_445_8			2	0.4	1.18E-04	HDAC4, HDDC3, F3	guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF], activation of blood coagulation via clotting cascade [BP], response to denervation involved in regulation of muscle adaptation [BP], activation of plasma proteins involved in acute inflammatory response [BP], positive regulation of platelet-derived growth factor receptor signaling pathway [BP]
CG_adsipsc_promoter_n_PM_14_77_4			1	0.2	6.60E-05	MAP3K5, MUL1	activation of JUN kinase activity [BP]
CG_adsipsc_promoter_n_PM_12_443_6			2	0.4	2.19E-04	NUP62	nucleocytoplasmic shuttling complex [CC]
CG_adsipsc_promoter_n_PM_12_253_8			2	0.4	4.87E-05	SLC13A4	sodium:sulfate symporter activity [MF]
CG_adsipsc_promoter_n_PM_12_272_9			3	0.4	3.38E-04	COL12A1, SLC30A1	collagen type XII [CC], negative regulation of zinc ion transmembrane import [BP]
CG_adsipsc_promoter_n_PM_12_220_13			1	0.2	5.97E-05	EDF1, INTS1, SHANK1, UBA7, TAF13	determination of affect [BP], somatostatin receptor binding [MF], ISG15 activating enzyme activity [MF], U2 snRNA 3'-end processing [BP], habituation [BP], transcription factor TFIID complex [CC]
CG_adsipsc_promoter_n_PM_12_29_11			1	0.2	5.88E-05	SLC52A3, ZC3H3	riboflavin transport [BP], regulation of mRNA export from nucleus [BP]
CG_adsipsc_promoter_n_PM_12_237_12			4	0.8	1.40E-05	SIK1	negative regulation of triglyceride biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_14_120_10			3	0.6	6.04E-05	GBE1, GLS2, TRPT1	tRNA 2'-phosphotransferase activity [MF], 1,4-alpha-glucan branching enzyme activity [MF], glutaminase activity [MF]
CG_adsipsc_promoter_n_PM_12_128_12			2	0.4	1.30E-04	LMAN2, ERGIC2	endoplasmic reticulum-Golgi intermediate compartment membrane [CC]
CG_adsipsc_promoter_n_PM_12_270_9			3	0.4	1.32E-04	SLC37A4, UXS1, TAF7	glucose-6-phosphate transmembrane transporter activity [MF], spermine transport [BP], UDP-D-xylose biosynthetic process [BP], UDP-glucuronate decarboxylase activity [MF]
CG_adsipsc_promoter_n_PM_12_426_10			3	0.6	1.07E-04	APOB, ATG3, ANKFY1, GIF, IRAK1, ST6GALNAC4	mature chylomicron [CC], (alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [MF], Atg8 ligase activity [MF], endosome [CC], chylomicron remnant [CC], endosome membrane [CC]
CG_adsipsc_promoter_n_PM_12_60_11			2	0.4	1.54E-04	NARS, FARSB	tRNA aminoacylation for protein translation [BP]
CG_adsipsc_promoter_n_PM_12_395_8			3	0.6	6.74E-05	BAZ1B, SRXN1, CHST10	vitamin D receptor activator activity [MF], sulfiredoxin activity [MF], HNK-1 sulfotransferase activity [MF], DNA replication-dependent nucleosome disassembly [BP]
CG_adsipsc_promoter_n_PM_12_175_9			2	0.4	1.24E-04	LAMB4, LEPREL1, DST	basement membrane [CC]
CG_adsipsc_promoter_n_PM_12_379_10			1	0.2	1.46E-04	HAUS4, NME7, NEK2, TUBGCP3, TBCK	centrosome [CC], protein kinase activity [MF]
CG_adsipsc_promoter_n_PM_12_338_9			1	0.2	2.69E-05	INPP5K, KLF4	negative regulation of protein kinase B signaling cascade [BP]
CG_adsipsc_promoter_n_PM_12_76_6			1	0.2	1.36E-04	PEX19	peroxisome membrane class-1 targeting sequence binding [MF], negative regulation of lipid binding [BP]
CG_adsipsc_promoter_n_PM_12_67_5			1	0.2	7.50E-05	ST8SIA5, LARGE	glycosphingolipid biosynthetic process [BP], integral to Golgi membrane [CC]
CG_adsipsc_promoter_n_PM_12_448_7			2	0.4	2.19E-04	BRCA1, TADA1, NOX1	positive regulation of histone H4-K20 methylation [BP], positive regulation of histone H3-K9 acetylation [BP], positive regulation of histone H4-K16 acetylation [BP], FADH2 metabolic process [BP], histone H3 acetylation [BP]
CG_adsipsc_promoter_n_PM_18_1_26			3	0.6	6.04E-05	PTGES, PTGES3	prostaglandin-E synthase activity [MF]
CG_adsipsc_promoter_n_PM_12_469_8			2	0.4	6.59E-05	LIF, AIPL1, BAD	positive regulation of histone H3-K27 acetylation [BP], RNA polymerase II transcription factor recruiting transcription factor activity [MF], positive regulation of protein localization to nucleus [BP], farnesylated protein binding [MF], cellular response to chromate [BP]
CG_adsipsc_promoter_n_PM_12_124_16			2	0.4	1.06E-04	SLC7A11, CHST10	cystine:glutamate antiporter activity [MF], HNK-1 sulfotransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_82_11			2	0.4	2.09E-04	MCM9	MCM8-MCM9 complex [CC]
CG_adsipsc_promoter_n_PM_14_24_11			3	0.4	3.34E-05	PIF1, ENO1	ATP-dependent 5'-3' DNA helicase activity [MF], magnesium ion binding [MF], phosphopyruvate hydratase complex [CC], single-stranded DNA-dependent ATP-dependent DNA helicase activity [MF], ATP-dependent 5'-3' DNA/RNA helicase activity [MF]
CG_adsipsc_promoter_n_PM_12_336_7			2	0.4	1.40E-04	MSRB1, CYP51A1, EXOSC10	nuclear retention of unspliced pre-mRNA at the site of transcription [BP], methionine-R-sulfoxide reductase activity [MF], cholesterol biosynthetic process via 24,25-dihydrolanosterol [BP], sterol 14-demethylase activity [MF]
CG_adsipsc_promoter_n_PM_18_5_57			3	0.6	3.17E-05	TGFBR3, MED24, CCNC, BRCA1	positive regulation of histone H4-K16 acetylation [BP], positive regulation of histone H3-K9 acetylation [BP], mediator complex [CC], negative regulation of centriole replication [BP], response to luteinizing hormone stimulus [BP], androgen receptor signaling pathway [BP], transforming growth factor beta receptor activity, type III [MF], positive regulation of histone H4-K20 methylation [BP], intracellular steroid hormone receptor signaling pathway [BP], BRCA1-BARD1 complex [CC]
CG_adsipsc_promoter_n_PM_12_420_9			3	0.6	6.60E-05	PKP2, BLOC1S5	endosome to melanosome transport [BP], desmosome assembly [BP], adherens junction maintenance [BP]
CG_adsipsc_promoter_n_PM_16_50_12			1	0.2	1.26E-04	HDAC8	chromatin assembly or disassembly [BP]
CG_adsipsc_promoter_n_PM_14_67_14			1	0.2	3.69E-05	SLC11A2, PPP4R1, MYH11	lead ion transmembrane transporter activity [MF], vanadium ion transmembrane transporter activity [MF], cobalt ion transmembrane transporter activity [MF], paraferritin complex [CC], nickel cation transport [BP], cadmium ion transmembrane transporter activity [MF], ferrous iron import [BP], lead ion transport [BP], protein phosphatase type 4 regulator activity [MF], ferrous iron transport [BP], ferrous iron transmembrane transporter activity [MF], nickel cation transmembrane transport [BP], skeletal muscle myosin thick filament assembly [BP], nickel cation transmembrane transporter activity [MF], manganese ion transmembrane transport [BP], smooth muscle contractile fiber [CC], vanadium ion transport [BP]
CG_adsipsc_promoter_n_PM_18_17_54			3	0.6	5.69E-06	DCAKD, PPP1R42	manchette [CC], dephospho-CoA kinase activity [MF]
CG_adsipsc_promoter_n_PM_12_392_14			3	0.6	2.20E-05	AMPD1	IMP salvage [BP], AMP deaminase activity [MF]
CG_adsipsc_promoter_n_PM_12_153_6			1	0.2	1.64E-04	TRA2A, CELF1, CELF3	nucleotide binding [MF]
CG_adsipsc_promoter_n_PM_12_6_9			2	0.4	4.31E-05	CD34, LEPREL1, BRF1	sulfate binding [MF], glomerular endothelium fenestra [CC], negative regulation of cellular response to hypoxia [BP], negative regulation of cellular response to heat [BP], transcription factor TFIIIB complex [CC], collagen metabolic process [BP], extracellular vesicular exosome assembly [BP], positive regulation of glial cell line-derived neurotrophic factor secretion [BP]
CG_adsipsc_promoter_n_PM_12_215_4			2	0.4	5.35E-05	FTCD, TEX14, TRPV4	glutamate formimidoyltransferase activity [MF], cortical microtubule organization [BP], formimidoyltetrahydrofolate cyclodeaminase activity [MF], intercellular bridge organization [BP], osmosensory signaling pathway [BP], osmosensor activity [MF]
CG_adsipsc_promoter_n_PM_12_337_11			2	0.4	1.97E-04	NAT8, PPP1R9B, CRHR2, HCFC1, ZDHHC11	cellular response to morphine [BP], corticotrophin-releasing factor receptor activity [MF], filopodium assembly [BP], release from viral latency [BP], transferase activity, transferring acyl groups [MF], N-acetyltransferase activity [MF], regulation of opioid receptor signaling pathway [BP]
CG_adsipsc_promoter_n_PM_12_239_7			2	0.2	5.43E-05	GJA5, GFPT1, ST3GAL2	gap junction channel activity involved in cardiac conduction electrical coupling [MF], AV node cell to bundle of His cell communication by electrical coupling [BP], atrial ventricular junction remodeling [BP], amino sugar metabolic process [BP], glucosamine biosynthetic process [BP], gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling [MF]
CG_adsipsc_promoter_n_PM_12_271_12			2	0.4	2.19E-05	MGARP	cellular response to gonadotropin-releasing hormone [BP]
CG_adsipsc_promoter_n_PM_12_433_11			2	0.4	5.08E-05	B3GALNT1	galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_56_7			2	0.4	5.75E-05	HDHD1, TIMP2, ATP13A2, AARSD1, B3GAT2, ZNHIT2	metal ion binding [MF]
CG_adsipsc_promoter_n_PM_20_13_110			1	0.2	3.84E-05	QRFP, POLE3, VGF, AGRP, POLE	neuropeptide hormone activity [MF], epsilon DNA polymerase complex [CC]
CG_adsipsc_promoter_n_PM_12_407_7			2	0.4	3.36E-05	KDM2B	initiation of neural tube closure [BP]
CG_adsipsc_promoter_n_PM_12_299_9			2	0.4	1.01E-04	ITGB2, SLC10A6, TAF9, MCRS1, APOA4	leukocyte cell-cell adhesion [BP], MLL1 complex [CC], sodium-dependent organic anion transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_PM_12_466_9			2	0.4	1.07E-04	C3AR1, UNKL	C3a anaphylatoxin receptor activity [MF], complement component C3a receptor activity [MF], ligase activity [MF]
CG_adsipsc_promoter_n_PM_16_31_7			1	0.2	3.16E-05	PHOX2A	locus ceruleus development [BP], trochlear nerve formation [BP]
CG_adsipsc_promoter_n_PM_12_151_8			2	0.4	1.04E-04	KIF6, CRHR2, DBC1, HDDC2, NPHP4, ANGPT2, TNFRSF13B, LZTS1, SYTL2	protein binding [MF], negative regulation of positive chemotaxis [BP], negative regulation of angiogenesis [BP]
CG_adsipsc_promoter_n_PM_14_22_10			1	0.2	6.69E-05	DTYMK	nucleoside monophosphate phosphorylation [BP], nucleoside phosphate kinase activity [MF]
CG_adsipsc_promoter_n_PM_12_269_10			1	0.2	5.60E-05	MTERF	termination of mitochondrial transcription [BP]
CG_adsipsc_promoter_n_PM_12_213_17			1	0.2	2.26E-04	PPP1R13L, STRA6	embryonic camera-type eye development [BP], alveolar primary septum development [BP], vitamin A import [BP]
CG_adsipsc_promoter_n_PM_12_34_16			2	0.4	8.94E-05	DOLK	dolichol kinase activity [MF], dolichyl monophosphate biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_12_109_11			3	0.4	1.14E-04	ZC3H3	regulation of mRNA export from nucleus [BP]
CG_adsipsc_promoter_n_PM_14_36_8			2	0.4	7.58E-05	KPTN, MPP1	stereocilium [CC]
CG_adsipsc_promoter_n_PM_12_373_8			1	0.2	1.01E-05	STRA6, CNGB1	intracellular cAMP activated cation channel activity [MF], intracellular cyclic nucleotide activated cation channel complex [CC], alveolar primary septum development [BP], vocal learning [BP], vitamin A import [BP]
CG_adsipsc_promoter_n_PM_12_100_13			2	0.4	1.92E-04	CARD11, NFAM1, NELFE, CD14, TMEM184A, EAPP, TLR9, NCBP2	regulation of secretion [BP], transcription elongation from RNA polymerase II promoter [BP], positive regulation of tumor necrosis factor production [BP], regulation of B cell differentiation [BP], positive regulation of cytokine production [BP], negative regulation of transcription elongation from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_PM_12_454_18			3	0.6	5.75E-05	SLC10A6, SLC2A2	hexose transmembrane transport [BP], sodium-dependent organic anion transmembrane transporter activity [MF], sodium-dependent organic anion transport [BP]
CG_adsipsc_promoter_n_PM_12_375_8			2	0.4	4.72E-05	TNKS1BP1, SYT2	nuclear telomeric heterochromatin [CC], neurotransmitter secretion [BP]
CG_adsipsc_promoter_n_PM_12_50_11			3	0.6	2.93E-04	CDCP2, BMP5, MSTN, FGF19, MUC13, LIF	negative regulation of steroid biosynthetic process [BP], cytokine activity [MF], extracellular region [CC], negative regulation of skeletal muscle tissue growth [BP], positive regulation of protein localization to nucleus [BP], RNA polymerase II transcription factor recruiting transcription factor activity [MF], growth factor activity [MF], positive regulation of histone H3-K27 acetylation [BP]
CG_adsipsc_promoter_n_PM_12_64_17			2	0.4	1.01E-05	DCTN1, TAS2R1, PKD1L3, EIF2AK3	activation of signaling protein activity involved in unfolded protein response [BP], taste receptor activity [MF], endoplasmic reticulum unfolded protein response [BP], response to endoplasmic reticulum stress [BP], sour taste receptor activity [MF], detection of chemical stimulus involved in sensory perception of taste [BP], detection of chemical stimulus involved in sensory perception of sour taste [BP]
CG_adsipsc_promoter_n_PM_12_131_7			2	0.4	1.22E-04	DPM3, CTSH	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [BP], HLA-A specific activating MHC class I receptor activity [MF]
CG_adsipsc_promoter_n_PM_14_95_4			1	0.2	9.54E-05	GPAM, SLC27A5	cholate-CoA ligase activity [MF], negative regulation of activation-induced cell death of T cells [BP]
CG_adsipsc_promoter_n_PM_12_165_12			2	0.4	1.45E-04	AP3D1	synaptic vesicle membrane organization [BP], antigen processing and presentation, exogenous lipid antigen via MHC class Ib [BP]
CG_adsipsc_promoter_n_PM_12_356_9			2	0.4	1.49E-04	KLK14, LILRB2	seminal clot liquefaction [BP], MHC class Ib protein binding [MF]
CG_adsipsc_promoter_n_PM_12_61_8			2	0.4	3.23E-05	DPH5	diphthine synthase activity [MF]
CG_adsipsc_promoter_n_PM_12_99_14			2	0.4	5.33E-05	BACE1	beta-aspartyl-peptidase activity [MF]
CG_adsipsc_promoter_n_PM_20_38_117			1	0.2	1.36E-05	DTYMK, GSK3A	negative regulation of type B pancreatic cell development [BP], negative regulation of cell growth involved in cardiac muscle cell development [BP], positive regulation of adrenergic receptor signaling pathway [BP], negative regulation of UDP-glucose catabolic process [BP], nucleoside phosphate kinase activity [MF], nucleoside monophosphate phosphorylation [BP], thymidylate kinase activity [MF], dTDP biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_14_39_21			4	0.8	6.35E-05	NODAL, SPAG5, CUL3, IL6ST	mitotic anaphase [BP], positive regulation vascular endothelial growth factor production [BP], anaphase [BP], trophectodermal cellular morphogenesis [BP]
CG_adsipsc_promoter_n_PM_16_58_33			3	0.6	4.11E-06	DPYD	dihydropyrimidine dehydrogenase (NADP+) activity [MF], thymidine catabolic process [BP], uracil catabolic process [BP], thymine catabolic process [BP], dihydroorotate oxidase activity [MF], beta-alanine biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_12_141_11			3	0.6	1.40E-04	TACR2, NOP14, NAGPA	prolactin secretion [BP], Noc4p-Nop14p complex [CC], N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [MF], substance K receptor activity [MF]
CG_adsipsc_promoter_n_PM_20_39_62			1	0.2	3.20E-05	KIAA0368, LMAN2L	ER to Golgi transport vesicle [CC]
CG_adsipsc_promoter_n_PM_12_176_6			1	0.2	1.29E-04	SLC1A2	visual behavior [BP]
CG_adsipsc_promoter_n_PM_12_9_5			2	0.4	4.43E-05	AFAP1L2, AGT	response to muscle activity involved in regulation of muscle adaptation [BP], positive regulation of extracellular matrix constituent secretion [BP], positive regulation of epidermal growth factor receptor signaling pathway [BP], ovarian follicle rupture [BP], astrocyte activation [BP], acetyltransferase activator activity [MF], positive regulation of protein tyrosine kinase activity [BP], positive regulation of NAD(P)H oxidase activity [BP], type 2 angiotensin receptor binding [MF], angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure [BP]
CG_adsipsc_promoter_n_PM_18_39_15			1	0.2	4.54E-05	RETSAT, PMVK	phosphomevalonate kinase activity [MF], all-trans-retinol 13,14-reductase activity [MF]
CG_adsipsc_promoter_n_PM_18_34_40			4	0.8	4.94E-05	CMPK2, PTPRT, DTYMK, DACT3, CDH24	delta-catenin binding [MF], thymidylate kinase activity [MF], dTDP biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_16_16_14			3	0.4	6.52E-05	AQP7, STK10, REV1	deoxycytidyl transferase activity [MF], polo kinase kinase activity [MF], urea channel activity [MF], error-prone translesion synthesis [BP]
CG_adsipsc_promoter_n_PM_12_290_6			2	0.4	3.35E-05	SLCO2A1, TFF2	prostaglandin transmembrane transporter activity [MF], CXCR4 chemokine receptor binding [MF]
CG_adsipsc_promoter_n_PM_12_54_8			2	0.4	9.74E-05	TREH, ELAVL2, TNR, SLC16A1, PARN, MB, MAP4, RHOA, TGFB1	defense response to fungus, incompatible interaction [BP], negative regulation of axonogenesis [BP], mitotic spindle organization [BP], microtubule sliding [BP], trehalose metabolic process [BP], slow-twitch skeletal muscle fiber contraction [BP], negative regulation of cell-cell adhesion [BP], mevalonate transport [BP], negative regulation of axon extension involved in regeneration [BP], negative regulation of hyaluronan biosynthetic process [BP], positive regulation of NAD+ ADP-ribosyltransferase activity [BP], trehalose catabolic process [BP], mRNA 3'-UTR binding [MF]
CG_adsipsc_promoter_n_PM_12_211_6			1	0.2	5.60E-05	ARSA, MVD	cerebroside-sulfatase activity [MF], diphosphomevalonate decarboxylase activity [MF]
CG_adsipsc_promoter_n_PM_12_52_12			2	0.4	1.69E-04	SMPD4	sphingomyelin phosphodiesterase D activity [MF]
CG_adsipsc_promoter_n_PM_12_406_20			1	0.2	3.51E-04	DEFB1, MASP2, C1QBP, TGFBR3	negative regulation of RIG-I signaling pathway [BP], mitochondrial ribosome binding [MF], acute inflammatory response [BP], negative regulation of MDA-5 signaling pathway [BP], positive regulation of trophoblast cell migration [BP], response to luteinizing hormone stimulus [BP], complement activation, classical pathway [BP], transforming growth factor beta receptor activity, type III [MF], innate immune response [BP], complement activation [BP], immune response [BP], positive regulation of mitochondrial translation [BP]
CG_adsipsc_promoter_n_PM_12_404_4			1	0.2	4.12E-04	TRPV3	negative regulation of hair cycle [BP]
CG_adsipsc_promoter_n_PM_18_19_46			3	0.6	5.03E-05	LAMP2, ABCC4	platelet dense granule membrane [CC]
CG_adsipsc_promoter_n_PM_12_282_11			3	0.6	1.16E-04	FLT3, MAP3K11	protein tyrosine kinase activity [MF], pro-T cell differentiation [BP], positive regulation of MAP kinase activity [BP], common myeloid progenitor cell proliferation [BP], protein autophosphorylation [BP], JUN kinase kinase kinase activity [MF]
CG_adsipsc_promoter_n_PM_12_89_13			3	0.6	2.38E-05	SPC24, RRAGC, NUP43, MAD1L1	cellular response to amino acid stimulus [BP], mitotic prometaphase [BP], kinetochore [CC], condensed chromosome kinetochore [CC]
CG_adsipsc_promoter_n_PM_12_368_15			4	0.8	4.90E-05	CCL19	positive regulation of glycoprotein biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_12_252_9			2	0.4	2.18E-05	ACIN1, PLEC, ADIPOR1, CTSH	cellular component disassembly involved in execution phase of apoptosis [BP], HLA-A specific activating MHC class I receptor activity [MF], hormone binding [MF]
CG_adsipsc_promoter_n_PM_12_399_8			1	0.2	1.65E-05	ECHDC1, G6PD	pentose biosynthetic process [BP], methylmalonyl-CoA decarboxylase activity [MF], glucose-6-phosphate dehydrogenase activity [MF], pentose-phosphate shunt, oxidative branch [BP], negative regulation of protein glutathionylation [BP]
CG_adsipsc_promoter_n_PM_14_96_14			2	0.4	1.89E-04	SERPINC1, SMAD7	regulation of proteolysis [BP], transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity [MF]
CG_adsipsc_promoter_n_PM_12_250_6			1	0.2	5.91E-04	ZNF432, SALL1, ZNF616, ZNF841	ureteric bud invasion [BP], olfactory bulb mitral cell layer development [BP], olfactory nerve development [BP], DNA binding [MF], inductive cell-cell signaling [BP], zinc ion binding [MF]
CG_adsipsc_promoter_n_PM_12_273_8			2	0.4	1.23E-04	QSOX2	thiol oxidase activity [MF]
CG_adsipsc_promoter_n_PM_12_300_12			3	0.4	7.71E-05	ATP2B2, CYP2D6, SLC25A16	antiporter activity [MF], negative regulation of cellular organofluorine metabolic process [BP], otolith mineralization [BP]
CG_adsipsc_promoter_n_PM_14_72_4			1	0.2	6.24E-05	SEPT4, CRP, C1D, COX7A1, SARS2	mitochondrion [CC]
CG_adsipsc_promoter_n_PM_12_358_15			1	0.2	5.68E-05	CALY, SARDH, PXN, UBA6	clathrin light chain binding [MF], sarcosine dehydrogenase activity [MF], BH4 domain binding [MF], FAT10 activating enzyme activity [MF]
CG_adsipsc_promoter_n_PM_12_134_11			1	0.2	4.50E-06	PGM3, FRZB	glucosamine metabolic process [BP], phosphoacetylglucosamine mutase activity [MF], negative regulation of hepatocyte differentiation [BP]
CG_adsipsc_promoter_n_PM_12_332_10			2	0.4	4.93E-05	SLC13A4, CBS	sodium:sulfate symporter activity [MF], homocysteine catabolic process [BP], cysteine biosynthetic process via cystathionine [BP], cystathionine beta-synthase activity [MF], transsulfuration [BP], cysteine biosynthetic process from serine [BP], hydrogen sulfide biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_12_482_20			4	0.6	3.61E-04	NFIB	negative regulation of mesenchymal cell proliferation involved in lung development [BP], negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP]
CG_adsipsc_promoter_n_PM_12_161_15			1	0.2	6.53E-05	PICALM	clathrin heavy chain binding [MF]
CG_adsipsc_promoter_n_PM_16_15_10			1	0.2	5.47E-05	ADRB3, MB21D1, TXNDC12, MLL2	oogenesis [BP], beta3-adrenergic receptor activity [MF], cyclic-GMP-AMP synthase activity [MF], protein-disulfide reductase (glutathione) activity [MF]
CG_adsipsc_promoter_n_PM_20_4_84			1	0.2	4.51E-05	UCN, PRKACA, KLF9, PHB, PRKAR2A	activation of protein kinase A activity [BP], progesterone receptor signaling pathway [BP]
CG_adsipsc_promoter_n_PM_14_40_12			5	1.0	3.21E-05	ITPK1	inositol tetrakisphosphate 1-kinase activity [MF], inositol-1,3,4-trisphosphate 6-kinase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF]
CG_adsipsc_promoter_n_PM_20_35_47			2	0.2	5.22E-05	SNRPD2, TFIP11, PSMA7, TXNL4B, DBR1, SNRNP40	spliceosomal complex [CC], catalytic step 2 spliceosome [CC], mRNA processing [BP], mRNA metabolic process [BP], mRNA splicing, via spliceosome [BP], RNA splicing [BP], RNA splicing, via transesterification reactions [BP]
CG_adsipsc_promoter_n_PM_12_20_20			4	0.8	1.24E-04	CH25H, SLC10A2	bile acid metabolic process [BP]
CG_adsipsc_promoter_n_PM_16_62_21			3	0.6	2.50E-05	LARS	leucine-tRNA ligase activity [MF], aminoacyl-tRNA editing activity [MF], leucyl-tRNA aminoacylation [BP]
CG_adsipsc_promoter_n_PM_12_305_9			1	0.2	8.51E-05	DHCR7, CBS	cysteine biosynthetic process via cystathionine [BP], 7-dehydrocholesterol reductase activity [MF], cystathionine beta-synthase activity [MF], cysteine biosynthetic process from serine [BP], homocysteine catabolic process [BP]
CG_adsipsc_promoter_n_PM_12_396_7			2	0.4	8.57E-05	KCNK10	potassium channel activity [MF]
CG_adsipsc_promoter_n_PM_20_30_86			1	0.2	4.08E-05	NACC2	intrinsic apoptotic signaling pathway in response to DNA damage [BP]
CG_adsipsc_promoter_n_PM_12_154_9			3	0.6	2.65E-04	PC	pyruvate carboxylase activity [MF]
CG_adsipsc_promoter_n_PM_14_42_10			3	0.6	2.39E-05	FKBP8, FKBP11, PIF1	protein peptidyl-prolyl isomerization [BP], ATP-dependent 5'-3' DNA/RNA helicase activity [MF], FK506 binding [MF], peptidyl-proline modification [BP], peptidyl-prolyl cis-trans isomerase activity [MF]
CG_adsipsc_promoter_n_PM_16_52_16			1	0.2	7.42E-05	ATE1, LARP4B, MAPK1	positive regulation of translation [BP], protein arginylation [BP], arginyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_218_19			2	0.4	6.85E-05	DBN1	cell communication by chemical coupling [BP]
CG_adsipsc_promoter_n_PM_12_7_5			3	0.6	4.06E-05	ZDHHC7	peptidyl-L-cysteine S-palmitoylation [BP]
CG_adsipsc_promoter_n_PM_14_98_8			3	0.6	4.12E-05	TAGAP, MTHFS, RPL30, VCP, GSR, KPNA3, SMAD2, GEMIN4, EIF2S2, SLBP	cytosol [CC]
CG_adsipsc_promoter_n_PM_12_68_8			3	0.6	1.25E-04	GPLD1, NHP2, OCA2, MESP1	GPI anchor release [BP], negative regulation of endodermal cell fate specification [BP], positive regulation of Notch signaling pathway involved in heart induction [BP], rRNA pseudouridine synthesis [BP], cardiac atrium formation [BP], L-tyrosine transmembrane transporter activity [MF], glycosylphosphatidylinositol phospholipase D activity [MF], cardioblast migration to the midline involved in heart field formation [BP], cardioblast anterior-lateral migration [BP], arsenite transport [BP], sinus venosus morphogenesis [BP], tyrosine transport [BP], cellular response to triglyceride [BP]
CG_adsipsc_promoter_n_PM_12_51_9			3	0.6	6.30E-05	KDM2B, GSS	glutathione synthase activity [MF], initiation of neural tube closure [BP]
CG_adsipsc_promoter_n_PM_12_295_13			1	0.2	1.78E-04	ACTN1, RBM39, TUBGCP6, PPP1R18	centrosome [CC], cytoskeleton [CC]
CG_adsipsc_promoter_n_PM_12_456_4			1	0.2	9.61E-05	ACVR1C	nodal binding [MF]
CG_adsipsc_promoter_n_PM_16_37_28			2	0.4	2.62E-05	APPBP2, VPS33A, HELZ2, PPP3CB, RBM39, CREBBP, MATN4, DDX23	protein binding [MF]
CG_adsipsc_promoter_n_PM_14_75_16			2	0.4	8.07E-05	GIP	positive regulation of glucagon secretion [BP]
CG_adsipsc_promoter_n_PM_12_117_10			2	0.4	1.74E-05	CYBA	smooth muscle hypertrophy [BP], negative regulation of glomerular filtration by angiotensin [BP]
CG_adsipsc_promoter_n_PM_12_98_6			3	0.6	5.99E-05	SLC25A17	FAD transmembrane transport [BP]
CG_adsipsc_promoter_n_PM_16_66_35			3	0.6	2.59E-05	NODAL, ITPK1	inositol-1,3,4-trisphosphate 6-kinase activity [MF], inositol-1,3,4-trisphosphate 5-kinase activity [MF], transforming growth factor beta receptor signaling pathway involved in primitive streak formation [BP], epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [BP], axial mesodermal cell fate specification [BP], inositol tetrakisphosphate 1-kinase activity [MF], type I activin receptor binding [MF], inhibition of neuroepithelial cell differentiation [BP]
CG_adsipsc_promoter_n_PM_12_447_12			2	0.4	3.37E-05	APTX	polynucleotide 3'-phosphatase activity [MF], DNA 5'-adenosine monophosphate hydrolase activity [MF]
CG_adsipsc_promoter_n_PM_14_27_28			4	0.8	3.24E-05	SALL4, MBD2, IL10	negative regulation of chronic inflammatory response to antigenic stimulus [BP], negative regulation of interferon-alpha biosynthetic process [BP], interleukin-10 receptor binding [MF], negative regulation of myeloid dendritic cell activation [BP], heterochromatin [CC]
CG_adsipsc_promoter_n_PM_14_79_10			2	0.4	3.78E-05	SLBP, PLBD1, WWTR1, AVP, RAB6A, RPL30, USP7, WDFY1, UBE2V1, SAR1B, CIDEC, PKM, CTSH	cytosol [CC]
CG_adsipsc_promoter_n_PM_12_470_11			2	0.2	2.13E-05	CAMK2N1, ATP8B3	calcium-dependent protein kinase inhibitor activity [MF], phospholipid translocation [BP]
CG_adsipsc_promoter_n_PM_16_63_24			5	1.0	2.19E-05	ALDH7A1, NKX2-1, ASIC2, PNMA1	central nervous system development [BP], menarche [BP], betaine-aldehyde dehydrogenase activity [MF], L-aminoadipate-semialdehyde dehydrogenase activity [MF]
CG_adsipsc_promoter_n_PM_12_190_8			2	0.2	1.88E-04	TACSTD2, GFRA4, SARS2	glial cell-derived neurotrophic factor receptor activity [MF], serine-tRNA ligase activity [MF], negative regulation of ruffle assembly [BP], negative regulation of substrate adhesion-dependent cell spreading [BP], seryl-tRNA aminoacylation [BP]
CG_adsipsc_promoter_n_PM_12_309_9			1	0.2	2.21E-05	SURF6, RDX	granular component [CC], microvillus assembly [BP]
CG_adsipsc_promoter_n_PM_16_40_15			1	0.2	1.24E-04	BAG5	negative regulation of protein refolding [BP], regulation of inclusion body assembly [BP]
CG_adsipsc_promoter_n_PM_12_481_12			1	0.2	5.40E-04	CCNB1IP1, SLC36A2, PAH	proline transmembrane transport [BP], phenylalanine 4-monooxygenase activity [MF], hydrogen:amino acid symporter activity [MF], meiotic metaphase I [BP]
CG_adsipsc_promoter_n_PM_12_194_9			1	0.2	6.98E-05	ANKH, SLC38A7, IDE, PRLR	positive regulation of protein oligomerization [BP], L-methionine transmembrane transporter activity [MF], insulin catabolic process [BP], prolactin signaling pathway [BP], beta-endorphin binding [MF], peptide hormone binding [MF], prolactin receptor activity [MF], L-leucine transmembrane transporter activity [MF], inorganic diphosphate transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_PM_12_130_7			3	0.6	7.47E-05	ACOX3	pristanoyl-CoA oxidase activity [MF]
CG_adsipsc_promoter_n_PM_12_307_9			2	0.4	3.05E-05	BST2	negative regulation of egress of virus within host cell [BP], negative regulation of plasmacytoid dendritic cell cytokine production [BP]
CG_adsipsc_promoter_n_PM_12_80_11			2	0.4	6.98E-05	HSD17B11	androgen catabolic process [BP]
CG_adsipsc_promoter_n_PM_14_8_13			3	0.4	9.64E-05	DACT2	negative regulation of nodal signaling pathway [BP], delta-catenin binding [MF], inner medullary collecting duct development [BP]
CG_adsipsc_promoter_n_PM_12_136_8			3	0.6	1.92E-04	CLIP1	macropinosome [CC]
CG_adsipsc_promoter_n_PM_12_472_4			4	0.6	9.65E-05	LSM4	U6 snRNP [CC]
CG_adsipsc_promoter_n_PM_12_2_10			1	0.2	2.10E-04	OXTR, PGAM2, GAS6, PID1	negative regulation of mitochondrial DNA replication [BP], oxytocin receptor activity [MF], 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [MF], cellular response to vitamin K [BP], negative regulation of renal albumin absorption [BP], negative regulation of oligodendrocyte apoptotic process [BP]
CG_adsipsc_promoter_n_PM_12_96_24			4	0.8	2.99E-05	QSOX2	thiol oxidase activity [MF]
CG_adsipsc_promoter_n_PM_14_105_13			4	0.8	5.87E-05	TTLL1, CDKN2D, MAP3K11	G1 phase of mitotic cell cycle [BP], tubulin-glutamic acid ligase activity [MF]
CG_adsipsc_promoter_n_PM_16_48_8			4	0.8	8.32E-05	MRPS18A, MRPS10, MRPS31	ribosome [CC], mitochondrial small ribosomal subunit [CC]
CG_adsipsc_promoter_n_PM_12_441_11			4	0.8	9.39E-05	POLDIP2, DNA2, FBXW7, SLC35B1	negative regulation of SREBP signaling pathway [BP], negative regulation of hepatocyte proliferation [BP], UDP-galactose transmembrane transport [BP], mitochondrial nucleoid [CC]
CG_adsipsc_promoter_n_PM_12_405_14			2	0.4	3.09E-04	SULT1A2, PAPSS1	3'-phosphoadenosine 5'-phosphosulfate metabolic process [BP]
CG_adsipsc_promoter_n_PM_16_45_145			6	1.0	6.77E-05	ALAS2	hemoglobin biosynthetic process [BP]
CG_adsipsc_promoter_n_PM_12_63_10			2	0.4	9.35E-05	POMGNT1	beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_398_11			2	0.4	9.08E-05	MB, CALY	clathrin light chain binding [MF], slow-twitch skeletal muscle fiber contraction [BP]
CG_adsipsc_promoter_n_PM_12_291_8			1	0.2	4.73E-05	HORMAD1	regulation of homologous chromosome segregation [BP], meiotic recombination checkpoint [BP], meiotic DNA double-strand break formation [BP]
CG_adsipsc_promoter_n_PM_12_55_6			2	0.4	1.46E-04	SFRP1, REV1	stromal-epithelial cell signaling involved in prostate gland development [BP], deoxycytidyl transferase activity [MF], convergent extension involved in somitogenesis [BP], positive regulation of fibroblast apoptotic process [BP], negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP], error-prone translesion synthesis [BP]
CG_adsipsc_promoter_n_PM_20_40_69			1	0.2	3.74E-05	RSPO1, UBR5, ASPM, STAT5B	canonical Wnt receptor signaling pathway [BP], positive regulation of canonical Wnt receptor signaling pathway [BP], positive regulation of Wnt receptor signaling pathway [BP], natural killer cell differentiation [BP]
CG_adsipsc_promoter_n_PM_12_32_15			5	0.8	5.36E-05	MAF, SLC7A11	lens fiber cell differentiation [BP]
CG_adsipsc_promoter_n_PM_12_329_9			1	0.2	1.38E-04	RHOA, UCP3, TUBB2B, ASCL2	protein polymerization [BP], response to hypoxia [BP]
CG_adsipsc_promoter_n_PM_12_62_7			2	0.4	3.95E-04	SNAPC4	snRNA-activating protein complex [CC], snRNA transcription [BP], snRNA transcription from RNA polymerase III promoter [BP], snRNA transcription from RNA polymerase II promoter [BP]
CG_adsipsc_promoter_n_PM_12_320_10			1	0.2	9.63E-05	CRYZ, NKX2-1	menarche [BP], NADPH:quinone reductase activity [MF], Clara cell differentiation [BP], negative regulation of cell migration [BP], globus pallidus development [BP]
CG_adsipsc_promoter_n_PM_12_47_9			2	0.4	3.15E-05	GCG, PCSK1	secretory granule [CC]
CG_adsipsc_promoter_n_PM_20_18_67			1	0.2	6.80E-05	CKM	cellular nitrogen compound metabolic process [BP]
CG_adsipsc_promoter_n_PM_14_56_23			4	0.8	4.87E-05	MLL2	oocyte growth [BP]
CG_adsipsc_promoter_n_PM_18_3_43			4	0.8	9.16E-05	TPT1, CKM	phosphocreatine biosynthetic process [BP], negative regulation of ectoderm development [BP]
CG_adsipsc_promoter_n_PM_16_17_34			5	1.0	1.45E-04	FLOT2	flotillin complex [CC]
CG_adsipsc_promoter_n_PM_12_275_10			4	0.6	1.49E-04	TAT	L-tyrosine:2-oxoglutarate aminotransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_43_17			2	0.4	3.79E-05	FSHR, PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 complex [CC], follicle-stimulating hormone receptor activity [MF]
CG_adsipsc_promoter_n_PM_18_41_169			4	0.8	5.90E-05	FBP1, IMPDH2, DCTPP1	protein homotetramerization [BP]
CG_adsipsc_promoter_n_PM_12_389_10			2	0.4	3.77E-05	PDGFB	negative regulation of phosphatidylinositol biosynthetic process [BP], superoxide-generating NADPH oxidase activator activity [MF], positive regulation of hyaluronan biosynthetic process [BP], paracrine signaling [BP], metanephric glomerular endothelium development [BP], metanephric glomerular mesangial cell development [BP], positive regulation of glomerular filtration [BP], cellular response to mycophenolic acid [BP], metanephric glomerular mesangial cell proliferation involved in metanephros development [BP], positive regulation of metanephric mesenchymal cell migration [BP], positive regulation of glomerular mesangial cell proliferation [BP], positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [BP]
CG_adsipsc_promoter_n_PM_12_436_14			2	0.4	1.32E-04	SDF4	zymogen granule exocytosis [BP]
CG_adsipsc_promoter_n_PM_12_382_14			2	0.4	8.33E-06	OTX2, NGLY1	peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [MF], eye photoreceptor cell fate commitment [BP]
CG_adsipsc_promoter_n_PM_14_97_12			2	0.4	1.21E-05	STK10	polo kinase kinase activity [MF]
CG_adsipsc_promoter_n_PM_14_80_12			3	0.6	8.44E-05	VWF	Weibel-Palade body [CC]
CG_adsipsc_promoter_n_PM_12_222_7			1	0.2	3.42E-05	GRM5	A2A adenosine receptor binding [MF], phospholipase C-activating G-protein coupled glutamate receptor signaling pathway [BP]
CG_adsipsc_promoter_n_PM_18_2_41			4	0.8	7.92E-05	CALB1, PKD1	metanephric collecting duct development [BP]
CG_adsipsc_promoter_n_PM_12_21_17			5	0.8	1.18E-04	KDM5B	histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP], histone demethylase activity (H3-trimethyl-K4 specific) [MF]
CG_adsipsc_promoter_n_PM_12_236_10			2	0.4	1.84E-04	TFF2, CCR1	chemokine-mediated signaling pathway [BP]
CG_adsipsc_promoter_n_PM_12_65_15			1	0.2	1.57E-05	MB, HSPA5, GJC1, TBX20	muscle contraction [BP], regulation of protein folding in endoplasmic reticulum [BP], embryonic heart tube elongation [BP], slow-twitch skeletal muscle fiber contraction [BP]
CG_adsipsc_promoter_n_PM_16_24_50			7	1.0	9.88E-05	TPM3, LMOD1, SNX4, SNX31	cytoskeleton [CC], protein transport [BP]
CG_adsipsc_promoter_n_PM_18_4_103			4	0.8	6.55E-05	CDX2, PLXDC1, ADA, CITED2, ZNF598, RAB17, EEF1G	intracellular [CC], trophectodermal cell differentiation [BP]
CG_adsipsc_promoter_n_PM_12_174_13			1	0.2	9.96E-05	IL5, SALL1, DST	ureteric bud invasion [BP], olfactory bulb mitral cell layer development [BP], positive regulation of eosinophil differentiation [BP], interleukin-5 receptor binding [MF], inductive cell-cell signaling [BP], H zone [CC]
CG_adsipsc_promoter_n_PM_12_266_11			1	0.2	3.23E-06	VWF, SLC30A1, DDO	D-amino-acid oxidase activity [MF], Weibel-Palade body [CC], negative regulation of zinc ion transmembrane import [BP], D-aspartate oxidase activity [MF], detoxification of cadmium ion [BP]
CG_adsipsc_promoter_n_PM_16_61_13			1	0.2	9.00E-05	AGXT2L1	ethanolamine-phosphate phospho-lyase activity [MF]
CG_adsipsc_promoter_n_PM_12_147_18			3	0.6	7.41E-05	NARFL, ETS1	estrous cycle phase [BP], PML body organization [BP], response to hypoxia [BP]
CG_adsipsc_promoter_n_PM_20_29_92			1	0.2	6.86E-05	GGA3, VNN1, GGA2, VNN2	pantetheine hydrolase activity [MF], ADP-ribosylation factor binding [MF]
CG_adsipsc_promoter_n_PM_12_341_5			1	0.2	3.62E-04	IL9, LAMTOR1	positive regulation of interleukin-5 biosynthetic process [BP], interleukin-9 receptor binding [MF], endosome localization [BP]
CG_adsipsc_promoter_n_PM_14_21_31			4	0.6	4.21E-05	CIB1, MDC1, CLN6	double-strand break repair [BP], locomotion involved in locomotory behavior [BP]
CG_adsipsc_promoter_n_PM_18_32_43			2	0.4	8.05E-05	EXOSC1, EXOSC6, ARSA, UNC93B1	exosome (RNase complex) [CC], exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [BP], lysosome [CC]
CG_adsipsc_promoter_n_PM_12_345_9			2	0.4	6.70E-05	DSCR3, SNX8	retromer complex [CC]
CG_adsipsc_promoter_n_PM_12_400_10			2	0.4	7.08E-06	NSUN2	tRNA methylation [BP], tRNA (cytosine-5-)-methyltransferase activity [MF]
CG_adsipsc_promoter_n_PM_12_37_6			5	0.8	1.40E-04	ANKLE2, NT5C2, DOHH, CRAT	carnitine O-acetyltransferase activity [MF], mitotic nuclear envelope reassembly [BP], nucleoside phosphotransferase activity [MF], deoxyhypusine monooxygenase activity [MF]
CG_adsipsc_promoter_n_PM_16_12_14			5	1.0	3.95E-05	GXYLT1, SLC25A1	carbohydrate metabolic process [BP]
CG_adsipsc_promoter_n_PM_12_268_13			1	0.2	2.28E-04	ANKLE2, TBXA2R, SLC22A17	integral to organelle membrane [CC], mitotic nuclear envelope reassembly [BP], thromboxane A2 receptor activity [MF]
CG_adsipsc_promoter_n_PM_12_434_8			1	0.2	2.69E-04	RELA	acetaldehyde metabolic process [BP]
CG_adsipsc_promoter_n_PM_14_60_12			2	0.4	4.74E-05	HSD17B14, HSD17B3	testosterone 17-beta-dehydrogenase (NADP+) activity [MF]
CG_adsipsc_promoter_n_PM_12_304_9			2	0.4	8.25E-05	CHCHD4	protein import into mitochondrial intermembrane space [BP]
CG_adsipsc_promoter_n_PM_18_8_30			2	0.4	3.00E-05	JUP, NUMB, SRSF12, ZFYVE1, CYTH3, LUC7L, PARD3	alpha-catenin binding [MF], phosphatidylinositol-3,4,5-trisphosphate binding [MF], RS domain binding [MF]
CG_adsipsc_promoter_n_PM_12_16_26			3	0.6	9.47E-05	AKR7A3, IRF7, ADRA1A	pilomotor reflex [BP], regulation of MyD88-dependent toll-like receptor signaling pathway [BP], negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [BP], negative regulation of macrophage apoptotic process [BP], norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [BP], establishment of viral latency [BP], regulation of MyD88-independent toll-like receptor signaling pathway [BP], positive regulation of the force of heart contraction by epinephrine-norepinephrine [BP], aflatoxin catabolic process [BP], alpha1-adrenergic receptor activity [MF]
CG_adsipsc_promoter_n_PM_12_380_7			2	0.4	2.91E-04	EIF6, SLC6A4, CCDC125	ribosomal subunit export from nucleus [BP], ribosomal large subunit binding [MF], serotonin:sodium symporter activity [MF], serotonin uptake [BP], intermediate filament cytoskeleton [CC], cocaine binding [MF], negative regulation of cerebellar granule cell precursor proliferation [BP], cellular response to cGMP [BP], serotonin transmembrane transporter activity [MF], negative regulation of synaptic transmission, dopaminergic [BP]
CG_adsipsc_promoter_n_PM_20_19_89			1	0.2	5.63E-05	ANO8, GRTP1, TADA3, SMC6, WASF2	intracellular [CC]
CG_adsipsc_promoter_n_PM_12_457_9			1	0.2	4.80E-05	CKB	creatine kinase activity [MF], cellular chloride ion homeostasis [BP]
CG_adsipsc_promoter_n_PM_12_245_17			2	0.4	2.38E-05	SYNE4, NR3C1, MEX3D	integral to nuclear outer membrane [CC], mRNA localization resulting in posttranscriptional regulation of gene expression [BP], glucocorticoid receptor activity [MF], mRNA destabilization [BP]
CG_adsipsc_promoter_n_PM_12_35_8			5	0.8	5.91E-05	SEPSECS	transferase activity, transferring selenium-containing groups [MF]
CG_adsipsc_promoter_n_PM_12_85_16			1	0.2	7.65E-05	SLC39A3	zinc ion transmembrane transporter activity [MF]
CG_adsipsc_promoter_n_PM_12_198_9			1	0.2	2.37E-04	PHLDA3, YPEL1	negative regulation of protein kinase B signaling cascade [BP]
CG_adsipsc_promoter_n_PM_12_224_6			1	0.2	2.18E-05	NRIP1	ovarian follicle rupture [BP]
CG_adsipsc_promoter_n_PM_12_208_9			2	0.4	1.97E-04	MFAP2, ADAT1	tRNA-specific adenosine deaminase activity [MF], fibrinogen binding [MF]
CG_adsipsc_promoter_n_PM_12_369_9			2	0.4	1.11E-04	TTLL1, TSHZ3	tubulin-glutamic acid ligase activity [MF], ureteric peristalsis [BP]
CG_adsipsc_promoter_n_PM_12_387_11			4	0.6	1.50E-04	PDIA6, YIF1A, MYO18A	endoplasmic reticulum-Golgi intermediate compartment [CC]
CG_adsipsc_promoter_n_PM_14_26_30			2	0.4	4.10E-05	AGMAT, SLC25A11	oxoglutarate:malate antiporter activity [MF], agmatinase activity [MF], putrescine biosynthetic process from arginine [BP]
CG_adsipsc_promoter_n_PM_12_411_8			1	0.2	3.10E-05	GFAP	positive regulation of Schwann cell proliferation [BP]
CG_adsipsc_promoter_n_PM_12_33_6			2	0.4	1.12E-04	IRS1, EPHA2, NR3C1	notochord cell development [BP], mammary gland development [BP], glucocorticoid receptor activity [MF], mammary gland duct morphogenesis [BP]
CG_adsipsc_promoter_n_PM_12_3_6			4	0.6	4.17E-05	BDNF, CPLX1, SMURF1	ectoderm development [BP], glutamate secretion [BP]
CG_adsipsc_promoter_n_PM_20_15_68			1	0.2	4.39E-05	LMO2, HDAC2, MLH3, SIX1, PATZ1	chromatin binding [MF]
CG_adsipsc_promoter_n_PM_20_2_114			1	0.2	4.69E-05	ACD, RFC2	telomere maintenance [BP]
CG_adsipsc_promoter_n_PM_12_240_10			3	0.6	4.58E-05	CHCHD4, TNPO3	protein import into mitochondrial intermembrane space [BP], splicing factor protein import into nucleus [BP]
CG_adsipsc_promoter_n_PM_12_229_13			3	0.6	1.48E-04	MZT2A, YIF1A, PLD6	P granule organization [BP], centrosome [CC], cardiolipin hydrolase activity [MF]
CG_adsipsc_promoter_n_PM_12_464_11			1	0.2	1.17E-04	SHPK, TMEM30A	cellular response to interleukin-13 [BP], protein localization to endosome [BP], sedoheptulokinase activity [MF]
CG_adsipsc_promoter_n_PM_12_105_13			2	0.4	2.88E-04	PIGZ, SEPHS1	mannosyltransferase activity [MF], alpha-1,2-mannosyltransferase activity [MF], selenide, water dikinase activity [MF], cellular protein modification process [BP]